Thanks @akanter for the updates Great work
December 18th release now on OCL! COVID-19 starter set also updated.
Just a preview of new content which is available from CIEL to support the latest in vaccination efforts. Currently in dropbox only. It also includes anatomical concepts requested by MSF:
“concept_id” “name” “Class” “Datatype” “description” “166356” “Intramuscular administration of 0.5 mL dose of preservative-free adenovirus type 26 DNA vector vaccine containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein transgene” “Procedure” “N/A” \N “166356” “Intramuscular administration of Janssen COVID-19 vaccine” “Procedure” “N/A” \N “166355” “JNJ-78436735 vaccine” “Drug” “N/A” \N “166355” “JANSSEN COVID-19 VACCINE” “Drug” “N/A” \N “166354” “Infection due to Brazil variant COVID-19” “Diagnosis” “N/A” \N “166354” “Infection due to COVID-19 P.1” “Diagnosis” “N/A” \N “166354” “Infection due to P.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N “166353” “Female genital organ” “Anatomy” “N/A” \N “166352” “Soft tissue of uterus” “Anatomy” “N/A” \N “166351” “Dorsal parametrium” “Anatomy” “N/A” \N “166350” “Lateral parametrium” “Anatomy” “N/A” \N “166349” “Peripheral nerve of upper limb” “Anatomy” “N/A” \N “166348” “Thumb and index finger” “Anatomy” “N/A” \N “166347” “Finger” “Anatomy” “N/A” \N “166346” “Shaft of humerus” “Anatomy” “N/A” \N “166346” “Humeral shaft” “Anatomy” “N/A” \N “166345” “Ilium” “Anatomy” “N/A” \N “166344” “Lateral neck” “Anatomy” “N/A” \N “166343” “Lateral plantar nerve” “Anatomy” “N/A” \N “166342” “Lower leg” “Anatomy” “N/A” \N “166341” “Anterior surface of lower leg” “Anatomy” “N/A” \N “166340” “Lower back” “Anatomy” “N/A” \N “166339” “Lower eyelid” “Anatomy” “N/A” \N “166338” “Lower limb” “Anatomy” “N/A” \N “166338” “Lower extremity” “Anatomy” “N/A” \N “166337” “Peripheral nerve of lower limb” “Anatomy” “N/A” \N “166336” “Lower lip” “Anatomy” “N/A” \N “166335” “Lower jaw” “Anatomy” “N/A” \N “166335” “Mandible” “Anatomy” “N/A” \N “166334” “Lumbar vertebra” “Anatomy” “N/A” \N “166333” “Maxillary nerve” “Anatomy” “N/A” \N “166333” “Maxillary branch of trigeminal nerve” “Anatomy” “N/A” \N “166332” “Medial plantar nerve” “Anatomy” “N/A” \N “166331” “Median nerve” “Anatomy” “N/A” \N “166330” “Metacarpal bone” “Anatomy” “N/A” \N “166329” “Metatarsal” “Anatomy” “N/A” \N “166328” “Mouth” “Anatomy” “N/A” \N “166327” “Neck” “Anatomy” “N/A” \N “166326” “Nose” “Anatomy” “N/A” \N “166325” “Palm” “Anatomy” “N/A” \N “166324” “Patella” “Anatomy” “N/A” \N “166323” “Pelvis” “Anatomy” “N/A” \N “166322” “Perineum” “Anatomy” “N/A” \N “166321” “Peroneal nerve” “Anatomy” “N/A” \N “166320” “Retroauricular sulcus” “Anatomy” “N/A” \N “166319” “Tip of elbow” “Anatomy” “N/A” \N “166319” “Posterior aspect of elbow” “Anatomy” “N/A” \N “166318” “Dorsal surface of wrist” “Anatomy” “N/A” \N “166318” “Dorsal aspect of wrist” “Anatomy” “N/A” \N “166317” “Pubis” “Anatomy” “N/A” \N “166316” “Head of radius” “Anatomy” “N/A” \N “166316” “Radial head” “Anatomy” “N/A” \N “166315” “Radial nerve” “Anatomy” “N/A” \N “166314” “Distal radius” “Anatomy” “N/A” \N “166313” “Proximal radius” “Anatomy” “N/A” \N “166312” “Shaft of radius” “Anatomy” “N/A” \N “166312” “Radial shaft” “Anatomy” “N/A” \N “166311” “Rib” “Anatomy” “N/A” \N “166310” “Sacrum” “Anatomy” “N/A” \N “166309” “Scalp” “Anatomy” “N/A” \N “166308” “Scapula” “Anatomy” “N/A” \N “166307” “Sciatic nerve” “Anatomy” “N/A” \N “166306” “Shoulder” “Anatomy” “N/A” \N “166305” “Shoulder joint” “Anatomy” “N/A” \N “166304” “Cranial bone” “Anatomy” “N/A” \N “166304” “Cranium” “Anatomy” “N/A” \N “166304” “Skull” “Anatomy” “N/A” \N “166303” “Sternoclavicular joint” “Anatomy” “N/A” \N “166302” “Sternum” “Anatomy” “N/A” \N “166301” “Stump” “Anatomy” “N/A” \N “166301” “Amputation stump” “Anatomy” “N/A” \N “166300” “Tarsus” “Anatomy” “N/A” \N “166300” “Tarsal bone” “Anatomy” “N/A” \N “166299” “Thigh” “Anatomy” “N/A” \N “166298” “Anterior surface of thigh” “Anatomy” “N/A” \N “166297” “Posterior surface of thigh” “Anatomy” “N/A” \N “166296” “Thoracic spine” “Anatomy” “N/A” \N “166295” “Thoracic vertebra” “Anatomy” “N/A” \N “166294” “Throat” “Anatomy” “N/A” \N “166294” “Anterior neck” “Anatomy” “N/A” \N “166293” “Thumb” “Anatomy” “N/A” \N “166292” “Distal tibia” “Anatomy” “N/A” \N “166291” “Proximal tibia” “Anatomy” “N/A” \N “166290” “Shaft of tibia” “Anatomy” “N/A” \N “166290” “Tibial shaft” “Anatomy” “N/A” \N “166289” “Tibial nerve” “Anatomy” “N/A” \N “166288” “Toe” “Anatomy” “N/A” \N “166287” “Trachea” “Anatomy” “N/A” \N “166286” “Distal ulna” “Anatomy” “N/A” \N “166285” “Proximal ulna” “Anatomy” “N/A” \N “166284” “Ulnar shaft” “Anatomy” “N/A” \N “166284” “Shaft of ulna” “Anatomy” “N/A” \N “166283” “Ulnar nerve” “Anatomy” “N/A” \N “166282” “Upper arm” “Anatomy” “N/A” \N “166281” “Upper eyelid” “Anatomy” “N/A” \N “166280” “Upper jaw” “Anatomy” “N/A” \N “166280” “Maxilla” “Anatomy” “N/A” \N “166279” “Upper limb” “Anatomy” “N/A” \N “166279” “Upper extremity” “Anatomy” “N/A” \N “166278” “Upper lip” “Anatomy” “N/A” \N “166277” “Wrist” “Anatomy” “N/A” \N “166276” “Urinary bladder” “Anatomy” “N/A” \N “166276” “Bladder” “Anatomy” “N/A” \N “166275” “Cervix uteri” “Anatomy” “N/A” \N “166275” “Uterine cervix” “Anatomy” “N/A” \N “166274” “■■■■■■■■” “Anatomy” “N/A” \N “166273” “Corpus uteri” “Anatomy” “N/A” \N “166273” “Body of uterus” “Anatomy” “N/A” \N “166272” “Fundus of uterus” “Anatomy” “N/A” \N “166271” “Isthmus uteri” “Anatomy” “N/A” \N “166271” “Isthmus of uterus” “Anatomy” “N/A” \N “166270” “Labia of vulva” “Anatomy” “N/A” \N “166269” “Ovary” “Anatomy” “N/A” \N “166268” “Peritoneum” “Anatomy” “N/A” \N “166267” “Placenta” “Anatomy” “N/A” \N “166266” “Frenulum of vulva” “Anatomy” “N/A” \N “166266” “Fourchette of vulva” “Anatomy” “N/A” \N “166265” “Rectum” “Anatomy” “N/A” \N “166264” “Retroperitoneum” “Anatomy” “N/A” \N “166263” “Ureter” “Anatomy” “N/A” \N “166262” “Urethra” “Anatomy” “N/A” \N “166261” “Uterine adnexa” “Anatomy” “N/A” \N “166260” “Uterine ligament” “Anatomy” “N/A” \N “166259” “Uterosacral ligament” “Anatomy” “N/A” \N “166258” “Infection due to South Africa variant COVID-19” “Diagnosis” “N/A” \N “166258” “Infection due to B.1.351 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N “166258” “Infection due to COVID-19 B.1.351” “Diagnosis” “N/A” \N “166257” “Infection due to UK variant COVID-19” “Diagnosis” “N/A” \N “166257” “Infection due to B.1.1.7 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N “166257” “Infection due to COVID-19 B.1.1.7” “Diagnosis” “N/A” \N “166256” “Uterus” “Anatomy” “N/A” \N “166255” “Parametrium” “Anatomy” “N/A” \N “166254” “Vulva” “Anatomy” “N/A” \N “166253” “Intramuscular administration of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N “166252” “Intramuscular administration of second dose of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N “166251” “Intramuscular administration of first dose of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N “166250” “BBIBP-CorV COVID-19 vaccine” “Drug” “N/A” \N “166250” “SINOPHARM COVID-19 VACCINE” “Drug” “N/A” \N “166249” “CoronaVac COVID-19 vaccine” “Drug” “N/A” \N “166249” “SINOVAC COVID-19 VACCINE” “Drug” “N/A” \N “166248” “Proximal humerus” “Anatomy” “N/A” \N “166248” “Humerus, proximal” “Anatomy” “N/A” \N “166247” “Humerus, distal” “Anatomy” “N/A” \N “166247” “Distal humerus” “Anatomy” “N/A” \N “166246” “Hip joint” “Anatomy” “N/A” \N “166245” “Hip” “Anatomy” “N/A” \N “166244” “Inguinal region” “Anatomy” “N/A” \N “166244” “Groin” “Anatomy” “N/A” \N “166243” “Gluteal region” “Anatomy” “N/A” \N “166243” “Buttock” “Anatomy” “N/A” \N “166242” “Forehead” “Anatomy” “N/A” “Includes eyebrow” “166242” “Forehead” “Anatomy” “N/A” “incluant les sourcils” “166241” “Forearm” “Anatomy” “N/A” \N “166240” “Foot, dorsal” “Anatomy” “N/A” \N “166240” “Dorsum of foot” “Anatomy” “N/A” \N “166239” “Shaft of fibula” “Anatomy” “N/A” \N “166239” “Fibular shaft” “Anatomy” “N/A” \N “166238” “Fibula, proximal” “Anatomy” “N/A” \N “166238” “Proximal fibula” “Anatomy” “N/A” \N “166237” “Fibula, distal” “Anatomy” “N/A” \N “166237” “Distal fibula” “Anatomy” “N/A” \N “166236” “Shaft of femur” “Anatomy” “N/A” \N “166236” “Femoral shaft” “Anatomy” “N/A” \N “166235” “Proximal femur” “Anatomy” “N/A” \N “166235” “Femur, proximal” “Anatomy” “N/A” \N “166234” “Distal femur” “Anatomy” “N/A” \N “166234” “Femur, distal” “Anatomy” “N/A” \N “166233” “Femoral nerve” “Anatomy” “N/A” \N “166232” “Facial bones” “Anatomy” “N/A” \N “166231” “Elbow” “Anatomy” “N/A” \N “166230” “Ear” “Anatomy” “N/A” \N “166229” “Dorsum of hand” “Anatomy” “N/A” \N “166229” “Dorsal face hand and finger” “Anatomy” “N/A” \N “166228” “Deltoid region” “Anatomy” “N/A” \N “166227” “Commissure of the lips” “Anatomy” “N/A” \N “166227” “Labial commissure” “Anatomy” “N/A” \N “166226” “Coccyx” “Anatomy” “N/A” \N “166225” “Clavicle” “Anatomy” “N/A” \N “166224” “Chin” “Anatomy” “N/A” \N “166223” “Chest wall” “Anatomy” “N/A” \N
I just noticed that Talk blanks out certain sensitive anatomical names :-o
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for January 29, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release included new concepts for additional COVID vaccination (so there are now concepts for Moderna, Pfizer, AstraZeneca, Sinopharm, Sputnik V and Janssen vaccines), concepts for the different variants of SARS-CoV-2, concepts for PIH and MSF including additional anatomic sites. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for June 6, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for COVID-19, PIH and KenyaEMR. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
> |concept_id|name|Class|Datatype|description|
> |---|---|---|---|---|
> |166477|Intramuscular administration of second dose of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166476|Intramuscular administration of first dose of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166475|Intramuscular administration of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166474|CureVac CVnCoV COVID-19 vaccine|Drug|N/A|\N|
> |166473|Patient's feelings regarding need for medication compliance|Question|Text|\N|
> |166472|Plan for dealing with medication side effects|Question|Text|\N|
> |166471|Plan for missed medication doses|Question|Text|\N|
> |166470|Medication administration and reminder tools|Question|Text|\N|
> |166469|Medication management plan|Question|Text|Patient plan for storing and administering medications|
> |166468|Knowledge level: HIV and treatment|Question|Text|Patient's understanding about HIV and treatment (ART)|
> |166467|Patient's rationale for high viral load|Question|Text|Narrative description of patient's explanation for why they have a high viral load.|
> |166466|Patient's feelings/reactions concerning test results|Question|Text|Narrative description of a patient's feelings or reactions to getting test results|
> |166465|Isoniazid / pyrazinamide / rifampin regimen|Misc|N/A|TB regimen including INH, Pyrazinamide and Rifampin (not necessarily in a single pill). For the single pill use Concept 768|
> |166464|HIV self-test performed|Question|Coded|Patient has been tested for HIV using a home-based self test.|
> |166463|Completed course of TB prophylaxis|Question|Coded|\N|
> |166463|Completed course of tuberculosis prophylaxis|Question|Coded|\N|
> |166462|Pneumocystis carinii pneumonia prophylaxis adherence|Question|Coded|Based on actual dispensed drugs, Good=>95%, Fair= 85-94%, Poor=<84%|
> |166462|PCP prophylaxis adherence|Question|Coded|Based on actual dispensed drugs, Good=>95%, Fair= 85-94%, Poor=<84%|
> |166461|Abacavir / Lamivudine / Lopinavir / Tenofovir|Misc|N/A|ART regimen used for HIV treatment|
> |166461|3TC/ABC/LPV/TDF|Misc|N/A|ART regimen used for HIV treatment|
> |166460|3TC/ABC/D4T|Misc|N/A|HIV ART regimen|
> |166460|Abacavir / Lamivudine / Stavudine|Misc|N/A|HIV ART regimen|
> |166459|Etravirine / lamivudine / lopinavir / tenofovir|Misc|N/A|HIV treatment regimen|
> |166459|3TC/ETV/LPV/TDF|Misc|N/A|HIV treatment regimen|
> |166458|Telephone contact/client tracing|Procedure|N/A|\N|
> |166458|Phone contact/client tracing|Procedure|N/A|\N|
> |166457|Physical contact/client tracing|Procedure|N/A|\N|
> |166456|Mode of contact/client tracing|Question|Coded|\N|
> |166455|Test kit lot number|Question|Text|\N|
> |166454|Human immunodeficiency virus testing kit type (text)|Question|Text|\N|
> |166453|Abbott SD Bioline HIV/Syphilis Duo test kit|Medical supply|N/A|\N|
> |166452|First response test kit|Medical supply|N/A|HIV test kit|
> |166452|Premier First Response(R) test kit|Medical supply|N/A|HIV test kit|
> |166451|Determine test kit|Medical supply|N/A|\N|
> |166451|Abbott Determine(R) test kit|Medical supply|N/A|\N|
> |166450|Human immunodeficiency virus testing kit type|Question|Coded|\N|
> |166450|HIV test kit type|Question|Coded|\N|
> |166449|Currently taking tuberculosis prophylaxis|Question|Coded|\N|
> |166449|Currently taking TB prophylaxis|Question|Coded|\N|
> |166448|Kenya differentiated care model type|Question|Coded|The type of medication delivery used in Kenya for HIV ART distribution.|
> |166447|Standard medication pickup following clinician visit|Procedure|N/A|\N|
> |166447|Standard care drug pickup following clinician visit|Procedure|N/A|\N|
> |166447|Standard pharmacy pickup following clinician visit|Procedure|N/A|\N|
> |166446|Fast track for drug pickup without clinician visit|Procedure|N/A|\N|
> |166446|Express medication pickup without clinician visit|Procedure|N/A|\N|
> |166446|Express pharmacy pickup without clinician visit|Procedure|N/A|\N|
> |166445|Facility group medication distribution|Procedure|N/A|\N|
> |166444|Community drug distribution, peer led|Procedure|N/A|\N|
> |166444|Community medication distribution, peer led|Procedure|N/A|\N|
> |166443|Community drug distribution, HCW led|Procedure|N/A|\N|
> |166443|Community medication distribution, healthcare worker led|Procedure|N/A|\N|
> |166442|ENT examination finding (text)|Question|Text|Free text entry for ENT exam findings|
> |166441|Eye examination findings (text)|Question|Text|Free text entry of eye exam findings. For coded answers use 163309|
> |166440|CNS exam performance status|Question|Coded|Was a CNS exam performed?|
> |166439|ENT exam performance status|Question|Coded|Was an ENT exam performed?|
> |166438|Obstructive mass of female genital tract|Diagnosis|N/A|\N|
> |166437|Status post perimortem caesarean section|Diagnosis|N/A|\N|
> |166437|Status post perimortem cesarean section|Diagnosis|N/A|\N|
> |166437|History of postmortem cesarean section|Diagnosis|N/A|\N|
> |166437|s/p perimortem c-section|Diagnosis|N/A|\N|
> |166436|Certificate of COVID-19 immunization/negative status|Misc|N/A|\N|
> |166436|COVID-19 Digital Health Pass|Misc|N/A|\N|
> |166435|COVID-19 clinical status based on WHO classification|Question|Numeric|\N|
> |166434|ETV + RAL + DRV/r|Misc|N/A|ARV regimen|
> |166434|Darunavir / etravirine / raltegravir / ritonavir|Misc|N/A|ARV regimen|
> |166433|Target population type|Question|Coded|\N|
> |166433|Key population type|Question|Coded|\N|
> |166432|Study population type|Question|Coded|\N|
> |166431|Key population|Misc|N/A|\N|
> |166431|Target population|Misc|N/A|\N|
> |166430|General population|Misc|N/A|The overall population of a studied group. A type of population often used as a denominator in an indicator.|
> |166429|History of pelvic reconstructive surgery|Diagnosis|N/A|\N|
> |166429|History of pelvis reconstruction|Diagnosis|N/A|\N|
> |166428|History of cervical cerclage|Diagnosis|N/A|\N|
> |166427|Prior trachelectomy|Diagnosis|N/A|\N|
> |166427|History of amputation of uterine cervix|Diagnosis|N/A|\N|
> |166427|History of trachelectomy|Diagnosis|N/A|\N|
> |166427|Status post removal of cervix|Diagnosis|N/A|\N|
> |166427|History of hysterotrachelectomy|Diagnosis|N/A|\N|
> |166426|History of retained placenta|Finding|N/A|\N|
> |166426|Previous retained placenta|Finding|N/A|\N|
> |166425|Assisted|Misc|N/A|\N|
> |166424|Placenta delivery method|Question|Coded|\N|
> |166423|Presence of prostate specific antigen (qualitative)|Test|Coded|\N|
> |166423|PSA present (qualitative)|Test|Coded|\N|
> |166422|Number of prior neonatal deaths|Question|Numeric|The number of live births who died within the first 28 days of life for an individual mother (prior to this pregnancy)|
> |166421|Adopts modern family planning method immediately post-partum|Question|Coded|\N|
> |166420|Lamivudine / Lopinavir / Tenofovir / Zidovudine|Misc|N/A|Regimen used for HIV|
> |166420|AZT/3TC/LPV/TDF|Misc|N/A|Regimen used for HIV|
> |166419|Placenta delivery method|Finding|Coded|\N|
> |166418|Male sex worker|Misc|N/A|\N|
> |166418|Male prostitute|Misc|N/A|\N|
> |166417|Transwoman|Finding|N/A|\N|
> |166417|Transgendered female|Finding|N/A|\N|
> |166416|Transman|Finding|N/A|\N|
> |166416|Transgendered male|Finding|N/A|\N|
> |166415|Transgender status|Finding|Coded|\N|
> |166414|Immune thrombocytopenia with thrombosis associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination|Diagnosis|N/A|\N|
> |166414|COVID-19 vaccine-associated immune thrombotic thrombocytopenia|Diagnosis|N/A|\N|
> |166413|South Africa variant|Misc|N/A|\N|
> |166413|B.1.351 variant|Misc|N/A|\N|
> |166412|India variant|Misc|N/A|\N|
> |166412|B.1.617 variant|Misc|N/A|\N|
> |166411|UK variant|Misc|N/A|\N|
> |166411|B.1.1.7 variant|Misc|N/A|\N|
> |166410|P.1 variant|Misc|N/A|\N|
> |166410|Brazil variant|Misc|N/A|\N|
> |166409|Wild type|Misc|N/A|Unmodified, non-mutated strain of organism|
> |166408|COVID-19 virus variant type|Question|Coded|\N|
> |166408|Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant type|Question|Coded|\N|
> |166407|Infection due to B.1.617 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
> |166407|Infection due to COVID-19 B.1.617|Diagnosis|N/A|\N|
> |166407|Infection due to India variant COVID-19|Diagnosis|N/A|\N|
> |166406|LY-CoV016|Drug|N/A|\N|
> |166406|Etesevimab|Drug|N/A|\N|
> |166405|Reconstruction of thumb from existing finger|Procedure|N/A|\N|
> |166405|Pollicisation of finger|Procedure|N/A|\N|
> |166404|Plastic repair by z plasty|Procedure|N/A|\N|
> |166403|Application of Plaster of Paris (POP)|Procedure|N/A|\N|
> |166402|Peripheral artery bypass|Procedure|N/A|\N|
> |166402|Peripheral artery shunt|Procedure|N/A|\N|
> |166402|Peripheral arterial bypass|Procedure|N/A|\N|
> |166401|Presence of red blood cells in stool test|Test|Coded|\N|
> |166401|Stool RBCs|Test|Coded|\N|
> |166401|Stool test for erythrocytes|Test|Coded|\N|
> |166400|Reason for caesarean delivery|Question|Coded|\N|
> |166400|Reason for cesarean delivery|Question|Coded|\N|
> |166400|Reason for c-section|Question|Coded|\N|
> |166399|severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibody measurement in serum or plasma by immunoassay (mass/volume)|Test|Numeric|\N|
> |166399|COVID-19 virus IgG antibody measurement in serum or plasma by immunoassay (mass/volume)|Test|Numeric|\N|
> |166398|Cyst of entamoeba|Organism|N/A|\N|
> |166398|Cyst of amoeba|Organism|N/A|\N|
> |166397|Mg|Test|Numeric|\N|
> |166397|Serum magnesium measurement (mg/dL)|Test|Numeric|\N|
> |166396|Fe|Test|Numeric|\N|
> |166396|Serum iron measurement (umol/L)|Test|Numeric|\N|
> |166395|Absolute reticulocyte count|Test|Numeric|\N|
> |166395|ARC|Test|Numeric|\N|
> |166394|Intramuscular administration of Sinopharm-Wuhan COVID-19 vaccine|Procedure|N/A|\N|
> |166393|Intramuscular administration of second dose of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166392|Intramuscular administration of first dose of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166391|Intramuscular administration of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166390|Novavax NVX-COV2373 COVID-19 vaccine|Drug|N/A|\N|
> |166389|Bharat Biotech Covaxin COVID-19 vaccine|Drug|N/A|\N|
> |166388|Intramuscular administration of Bharat Biotech Covaxin COVID-19 vaccine|Procedure|N/A|\N|
> |166387|Intramuscular administration of Chumakov Center KoviVac COVID-19 vaccine|Procedure|N/A|\N|
> |166387|Intramuscular administration of Chumakov Center CoviVac COVID-19 vaccine|Procedure|N/A|\N|
> |166386|Chumakov Center Kovivac COVID-19 vaccine|Drug|N/A|\N|
> |166386|Chumakov Center Covivac COVID-19 vaccine|Drug|N/A|\N|
> |166385|Intramuscular administration of Vector Institute EpiVacCorona COVID-19 vaccine|Procedure|N/A|\N|
> |166384|Vector Institute EpivacCorona COVID-19 vaccine|Drug|N/A|\N|
> |166383|Mono-drug resistant tuberculosis infection|Diagnosis|N/A|\N|
> |166383|Mono-drug resistant TB infection|Diagnosis|N/A|\N|
> |166382|High protein liquid nutritional supplement|Misc|N/A|\N|
> |166382|Pediasure|Misc|N/A|\N|
> |166381|Intramuscular administration of CanSinoBIO Ad5-nCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166381|Intramuscular administration of CanSinoBIO Convidicea COVID-19 vaccine|Procedure|N/A|\N|
> |166380|Intramuscular administration of Sinovac CoronaVac COVID-19 vaccine|Procedure|N/A|\N|
> |166379|Sinopharm-Wuhan COVID-19 vaccine|Drug|N/A|\N|
> |166378|Ad5-nCoV COVID-19 Vaccine|Drug|N/A|\N|
> |166378|Cansino Biologics Convidicea COVID-19 vaccine|Drug|N/A|\N|
> |166377|Fibrinogen activity|Test|Numeric|\N|
> |166377|Fibrinogen assay|Test|Numeric|\N|
> |166376|Plasma TT|Test|Numeric|\N|
> |166376|Plasma thrombin time (seconds)|Test|Numeric|\N|
> |166375|Disseminated intravascular coagulation (DIC) screening panel |LabSet|N/A|\N|
> |166374|Comprehensive metabolic panel|LabSet|N/A|\N|
> |166373|Infection due to B.1.526 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
> |166373|Infection due to COVID-19 B.1.526|Diagnosis|N/A|\N|
> |166372|Application of cartilage graft|Procedure|N/A|\N|
> |166371|Medial condyle of elbow|Anatomy|N/A|\N|
> |166371|Medial condyle of humerus|Anatomy|N/A|\N|
> |166370|Lateral condyle of humerus|Anatomy|N/A|\N|
> |166370|Lateral condyle of elbow|Anatomy|N/A|\N|
> |166369|Dimethicone / pinaverium|Drug|N/A|\N|
> |166368|Disposable menstrual product|Misc|N/A|\N|
> |166367|Relacid|Drug|N/A|\N|
> |166367|Tena Cid|Drug|N/A|\N|
> |166367|Rantac Mps|Drug|N/A|\N|
> |166367|Dimethicone / magaldrate|Drug|N/A|\N|
> |166366|Entresto|Drug|N/A|\N|
> |166366|Sacubitril / valsartan|Drug|N/A|\N|
> |166365|History of traditional medicine practice/procedure|Finding|Coded|\N|
> |166364|Female genital exam finding (text)|Finding|Text|\N|
> |166364|Gynecological examination (text)|Finding|Text|\N|
> |166363|Urological examination (text)|Question|Text|\N|
> |166363|Urinary system finding (text)|Question|Text|\N|
> |166362|Female genital exam finding|Finding|Coded|\N|
> |166362|Gynecological exam finding|Finding|Coded|\N|
> |166361|Duration of alcohol use (years)|Finding|Numeric|\N|
> |166360|Tracheotomy|Procedure|N/A|\N|
> |166359|Sinusectomy|Procedure|N/A|\N|
> |166358|Urinary system findings|Finding|Coded|\N|
> |166358|Urological exam findings|Finding|Coded|\N|
> |166357|Occiput posterior presentation|Finding|N/A|Fetal malposition where back of head presents first posteriorly.|
This version is now published on OCL as well as the COVID-19 starter-set collection.
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for July 5, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0!
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for COVID-19, PIH and KenyaEMR. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
concept_id | name | Class | Datatype | description |
---|---|---|---|---|
166533 | Pharyngotonsillitis | Diagnosis | N/A | \N |
166532 | World Health Organization Partograph | ConvSet | N/A | \N |
166531 | Pitocin drip dose (drops/min) | Question | Numeric | \N |
166531 | Oxytocin drip dose (drops/min) | Question | Numeric | \N |
166530 | Pitocin concentration (U/L) | Question | Numeric | \N |
166530 | Oxytocin concentration (U/L) | Question | Numeric | \N |
166529 | Frequency of uterine contractions within 10 minute period | Question | Numeric | \N |
166528 | Descent of fetal head in relation to ischial spines | Question | Numeric | Proportion of head above spines out of 5 |
166527 | Fetal moulding score | Question | Coded | \N |
166527 | Degree of foetal moulding | Question | Coded | \N |
166526 | Alcohol and Drug Abuse Assessment screening results | Question | Coded | \N |
166525 | Personal life ambitions | Question | Text | \N |
166525 | Personal life ambitions (text) | Question | Text | \N |
166524 | PASP (pulmonary artery systolic pressure) | Question | Numeric | \N |
166524 | sPAP | Question | Numeric | \N |
166524 | Pulmonary artery systolic pressure (mmHg) | Question | Numeric | \N |
166523 | Infection due to B.1.617.2 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | Diagnosis | N/A | \N |
166523 | Infection due to Delta variant COVID-19 | Diagnosis | N/A | \N |
166523 | Infection due to COVID-19 B.1.617.2 | Diagnosis | N/A | \N |
166522 | 3TC + DRV/r + RAL + TDF | Misc | N/A | ARV regimen |
166522 | Darunavir / Lamivudine / Raltegravir / Ritonavir / Tenofovir | Misc | N/A | ARV regimen |
166522 | 3TC/DRV/RAL/RTV/TDF | Misc | N/A | ARV regimen |
166521 | 3TC + DTG + DRV/r + TDF | Misc | N/A | ARV regimen |
166521 | Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir | Misc | N/A | ARV regimen |
166521 | 3TC/DAL/DRV/DTG/RTV | Misc | N/A | ARV regimen |
166520 | Ended pregnancy since last visit | Question | Coded | \N |
166520 | Terminated pregnancy since last visit | Question | Coded | \N |
166519 | Screening not done | Finding | N/A | \N |
166519 | Screening not performed | Finding | N/A | \N |
166518 | Ineligible for screening | Finding | N/A | \N |
166518 | Screening not needed | Finding | N/A | \N |
166517 | Shares drug injecting equipment | Finding | N/A | \N |
166517 | Shares needles and/or syringes | Finding | N/A | \N |
166516 | Unreliable condom use | Finding | N/A | Person uses condoms for sex either inconsistently or never at all. |
166515 | Referred for family planning services | Procedure | Coded | \N |
166514 | Misuses drugs other than intravenously | Finding | N/A | \N |
166514 | Non-intravenous drug user | Finding | N/A | \N |
166513 | Female prostitute | Misc | N/A | \N |
166513 | Female sex worker | Misc | N/A | \N |
166512 | Peer educator | Finding | Coded | \N |
166511 | Description of physical abuse | Question | Text | \N |
166510 | Year began injecting drugs | Question | Numeric | Calendar year when person began injecting drugs |
166510 | Year started IVDU | Question | Numeric | Calendar year when person began injecting drugs |
166509 | Year man started having sex with men | Question | Numeric | The first year that a male starting having sex with other men. |
166508 | Year started sex work | Question | Numeric | The calendar year that the person began having sex for payment. |
166507 | Consent given to contact partner | Finding | Coded | \N |
166506 | Name of sexual partner | Question | Text | \N |
166505 | Has regular sex partner | Question | Coded | Patient has a regular partner for sexual activity |
166504 | Number of IVDU per week | Question | Numeric | Average number of drug injections per week |
166504 | Number of drug injection episodes per week | Question | Numeric | Average number of drug injections per week |
166503 | Number of drug injection times per day | Question | Numeric | \N |
166503 | Number of IVDU per day | Question | Numeric | \N |
166502 | Number of anal sex acts per week | Question | Numeric | \N |
166501 | Number of sex acts per week | Question | Numeric | Average number of any form of sexual activity per week |
166500 | Name of transmission hotspot | Question | Text | Name of location where disease transmission is likely to occur. |
166499 | Barber shop/beauty salon | Misc | N/A | \N |
166498 | Strip club | Misc | N/A | \N |
166497 | Brothel | Misc | N/A | \N |
166496 | Hotel | Misc | N/A | \N |
166495 | Massage parlor | Misc | N/A | \N |
166495 | Massage parlour | Misc | N/A | \N |
166494 | Drinking bar | Misc | N/A | Drinking bar without lodging |
166493 | Drinking bar with lodging | Misc | N/A | |
166493 | Hotel bar | Misc | N/A | |
166492 | Casino | Misc | N/A | \N |
166491 | Beach | Misc | N/A | \N |
166490 | Public park | Misc | N/A | \N |
166489 | Derelict building | Misc | N/A | \N |
166489 | Uninhabitable building | Misc | N/A | \N |
166488 | On the street | Misc | N/A | Location or environment |
166488 | In the street | Misc | N/A | Location or environment |
166487 | Treatment adherence plan | Question | Text | \N |
166486 | Patient benefited from home visit | Question | Coded | \N |
166485 | Patient experience with referral (text) | Question | Text | \N |
166484 | Patient attended last scheduled appointment | Question | Coded | \N |
166483 | Patient treated differently upon disclosure of health status | Finding | Coded | \N |
166482 | Patient concerned about accidental disclosure of health status | Finding | Coded | \N |
166482 | Patient worried about accidental disclosure of health status | Finding | Coded | \N |
166481 | B.1.617.2 variant | Misc | N/A | Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant |
166481 | Delta variant | Misc | N/A | Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant |
166480 | B.1.429 variant | Misc | N/A | S13I, W152C, L452R, D614G California variant |
166479 | B.1.427 variant | Misc | N/A | L452R, D614G California variant |
166478 | Resolved Post-Acute Sequelae of SARS-CoV-2 infection (PASC) | Diagnosis | N/A | \N |
166478 | Resolved post-COVID-19 syndrome | Diagnosis | N/A | \N |
COVID-19 Starter set collection has also been updated for the new release.
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for September 2, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for KenyaEMR, BandaHealth, PIH and COVID-19. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
|concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|166654|Suspected HSIL with full extent of lesion visualized|Finding|N/A|\N|
|166654|Suspect HSIL fully seen|Finding|N/A|\N|
|166654|Suspected high grade squamous intraepithelial lesion (HGSIL) with full extent of lesion seen|Finding|N/A|\N|
|166653|Cause of injury, qualitative|Question|Coded|\N|
|166652|Arthrolysis|Procedure|N/A|\N|
|166651|Advancement of flap|Procedure|N/A|\N|
|166650|Volume administered (ml)|Question|Numeric|\N|
|166649|Date of injury|Question|Date|\N|
|166648|Cause of burn|Question|Coded|\N|
|166647|Number of specimen(s) collected|Question|Numeric|\N|
|166647|Number of samples (s) collected|Question|Numeric|\N|
|166646|Associated injury|Question|Coded|\N|
|166645|Aceto-white areas visualized on the cervix|Symptom/Finding|N/A|\N|
|166644|Endocervical curettage performed|Question|Coded|\N|
|166643|Uterine cervix fully visualized|Finding|N/A|\N|
|166643|Uterine cervix fully visualised|Finding|N/A|\N|
|166643|Uterine cervix fully seen|Finding|N/A|\N|
|166642|Uterine cervix not visualized|Finding|N/A|\N|
|166642|Uterine cervix not seen|Finding|N/A|\N|
|166642|Uterine cervix not visualised|Finding|N/A|\N|
|166641|Uterine cervix visibility|Question|Coded|\N|
|166640|Fertility intentions|Question|Coded|\N|
|166639|Initial health education received|Question|Coded|\N|
|166639|Initial health education given|Question|Coded|\N|
|166638|Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Question|Coded|\N|
|166638|COVID-19 test status|Question|Coded|\N|
|166637|Referring facility type, non-coded|Question|Text|\N|
|166636|Referring facility type|Question|Coded|\N|
|166635|Procedure performed (text)|Question|Text|\N|
|166634|Patient does not want to get pregnant|Finding|N/A|\N|
|166634|Patient does not wish to get pregnant|Finding|N/A|\N|
|166633|History of obstetrical complication (text)|Diagnosis|Text|\N|
|166632|Suturing|Procedure|N/A|\N|
|166632|Closure by suture|Procedure|N/A|\N|
|166631|Haemostatic technique (text)|Question|Text|\N|
|166631|Hemostatic technique (text)|Question|Text|\N|
|166631|Hemostasis technique (text)|Question|Text|\N|
|166630|Electrocautery operation|Procedure|N/A|\N|
|166630|Electrocautery procedure|Procedure|N/A|\N|
|166629|Hemostatic technique|Question|Coded|\N|
|166629|Hemostasis technique|Question|Coded|\N|
|166629|Haemostasis technique|Question|Coded|\N|
|166628|Encounter for antenatal care|Diagnosis|N/A|\N|
|166628|Supervision of normal pregnancy|Diagnosis|N/A|\N|
|166627|Encounter for immunization|Diagnosis|N/A|\N|
|166627|Vaccination visit|Diagnosis|N/A|\N|
|166626|Encounter for routine circumcision|Diagnosis|N/A|\N|
|166625|Postpartum visit|Diagnosis|N/A|\N|
|166625|Encounter for routine postpartum follow-up|Diagnosis|N/A|\N|
|166625|Postpartum care follow-up|Diagnosis|N/A|\N|
|166624|On sick leave from work|Diagnosis|N/A|\N|
|166624|Out sick|Diagnosis|N/A|\N|
|166623|Suspected malaria|Diagnosis|N/A|\N|
|166623|Presumptive malaria|Diagnosis|N/A|\N|
|166622|Encounter for screening for human immunodeficiency virus|Diagnosis|N/A|\N|
|166622|Screen for HIV|Diagnosis|N/A|\N|
|166622|Encounter for HIV screening|Diagnosis|N/A|\N|
|166621|Endocervical biopsy|Procedure|N/A|\N|
|166621|Endocervical bx|Procedure|N/A|\N|
|166621|Biopsy of endocervix|Procedure|N/A|\N|
|166620|Loop electrosurgical excision procedure (LEEP) indication|Question|Coded|\N|
|166620|LEEP indication|Question|Coded|\N|
|166619|Suspect HSIL SJC not fully seen|Finding|N/A|\N|
|166619|Suspected high grade squamous intraepithelial lesion (HGSIL) with squamocolumnar junction (SJC) not fully visualized|Finding|N/A|\N|
|166618|Suspect HSIL ext into cervical canal|Finding|N/A|\N|
|166618|Suspected high grade squamous intraepithelial lesion (HGSIL) with lesion extending into the cervical canal|Finding|N/A|\N|
|166617|Suspect HSIL >75% cervix|Finding|N/A|\N|
|166617|Suspected high grade squamous intraepithelial lesion (HGSIL) > 75 % of the cervical surface|Finding|N/A|\N|
|166616|Endocervical curettage|Procedure|N/A|\N|
|166616|Curettage of endocervix|Procedure|N/A|\N|
|166615|Unintentional injury|Diagnosis|N/A|\N|
|166615|Accidental injury|Diagnosis|N/A|\N|
|166614|Tendon injury|Diagnosis|N/A|\N|
|166613|Qualitative blood culture result|Question|Coded|\N|
|166612|Burned due to contact with hot solid object or material|Diagnosis|N/A|\N|
|166612|Burn due to contact with hot surface|Diagnosis|N/A|\N|
|166611|Burn caused by fire|Diagnosis|N/A|\N|
|166611|Burn caused by open flame|Diagnosis|N/A|\N|
|166611|Burn caused by open fire|Diagnosis|N/A|\N|
|166610|Superficial partial thickness burn|Diagnosis|N/A|\N|
|166610|Superficial second degree burn|Diagnosis|N/A|\N|
|166609|Deep second degree burn|Diagnosis|N/A|\N|
|166609|Deep partial thickness burn|Diagnosis|N/A|\N|
|166608|Burn caused by hot liquid|Diagnosis|N/A|\N|
|166608|Hot liquid burn|Diagnosis|N/A|\N|
|166607|Willing to receive reminders/notifications about upcoming appointments|Finding|Coded|\N|
|166606|Patient has access to social support people or network|Question|Coded|\N|
|166605|List of patient's treatment supporters|Question|Text|Narrative list of treatment supporters, including groups, community resources, etc.|
|166604|Admit weight|Finding|Numeric|Body weight on admission to hospital|
|166604|Weight on admission (kg)|Finding|Numeric|Body weight on admission to hospital|
|166603|Frequency of requiring a morning alcoholic drink over past year|Question|Coded|\N|
|166603|Frequency of requiring an alcoholic eye-opener over past year|Question|Coded|\N|
|166602|Frequency of failing to achieve a goal due to alcohol over past year|Question|Coded|\N|
|166601|Frequency of not being able to stop drinking alcohol over past year|Question|Coded|\N|
|166600|How often 6+ alcoholic drinks at one time|Question|Coded|\N|
|166600|Frequency of having six or more alcoholic drinks on one occasion|Question|Coded|\N|
|166599|Patient refused to seek treatment due to fear of stigma|Finding|N/A|\N|
|166598|Challenging situations to administer medications|Question|Text|Text description of challenging/difficult situations where patient has to to take drugs/medications|
|166598|Difficult situations to take medication|Question|Text|Text description of challenging/difficult situations where patient has to to take drugs/medications|
|166597|Patient enrollment category|Question|Coded|\N|
|166596|Transit patient|Misc|N/A|A patient who is being seen outside of their regular care setting temporarily to receive medication refills, etc.|
|166596|Transient patient|Misc|N/A|A patient who is being seen outside of their regular care setting temporarily to receive medication refills, etc.|
|166595|Site of injury|Question|Coded|\N|
|166595|Injury site|Question|Coded|\N|
|166594|Burn site|Question|Coded|\N|
|166593|Total body surface area (TBSA) percent|Question|Numeric|\N|
|166593|TBSA (%)|Question|Numeric|\N|
|166592|Circumferential burn|Question|Coded|\N|
|166591|Trephine biopsy|Test|Coded|\N|
|166590|Patient Health Questionnaire-4 (PHQ-4) score|Question|Numeric|\N|
|166590|PHQ-4 score|Question|Numeric|\N|
|166589|VAS score|Question|Numeric|\N|
|166589|Visual analog scale pain score|Question|Numeric|\N|
|166588|Face, Legs, Activity, Cry, Consolability (FLACC) score|Finding|Numeric|\N|
|166587|Douleur Neuropathique 4 score|Finding|Numeric|\N|
|166587|DN4 score|Finding|Numeric|\N|
|166586|HTS strategy|Question|Coded|\N|
|166586|HIV testing services strategy|Question|Coded|\N|
|166585|Patient testing context|Question|Coded|\N|
|166585|Patient tested as|Question|Coded|\N|
|166584|Couple|Misc|N/A|Two persons together|
|166583|Individual|Misc|N/A|\N|
|166583|Individual person|Misc|N/A|\N|
|166582|Non-provider-initiated HIV testing and counseling|Procedure|N/A|\N|
|166581|Stand-alone voluntary counseling and testing center|Misc|N/A|\N|
|166581|Standalone VCT centre|Misc|N/A|\N|
|166580|WHO|Misc|N/A|\N|
|166580|World Health Organization|Misc|N/A|\N|
|166579|Doctors Without Borders|Misc|N/A|\N|
|166579|MSF|Misc|N/A|\N|
|166578|UNRWA|Misc|N/A|\N|
|166578|United Nations Relief and Works Agency|Misc|N/A|\N|
|166577|Ministry of Health|Misc|N/A|\N|
|166577|MOH|Misc|N/A|\N|
|166576|Non-governmental organization facility|Misc|N/A|\N|
|166576|NGO facility|Misc|N/A|\N|
|166575|DOB|Question|Date|\N|
|166575|Date of birth|Question|Date|\N|
|166575|Birthdate|Question|Date|\N|
|166574|Middle name|Question|Text|\N|
|166573|Medial|Misc|N/A|Anatomic direction as opposed to lateral.|
|166572|Condyloma acuminatum of vagina|Diagnosis|N/A|\N|
|166572|Vaginal condyloma acuminatum|Diagnosis|N/A|\N|
|166571|Vulvar condyloma acuminatum|Diagnosis|N/A|\N|
|166571|Condyloma acuminatum of vulva|Diagnosis|N/A|\N|
|166570|Relationship to index case|Question|Coded|\N|
|166570|Relationship to index client|Question|Coded|\N|
|166569|Diarrhea with dehydration|Diagnosis|N/A|\N|
|166568|Encounter for removal of stitches|Diagnosis|N/A|\N|
|166568|Encounter for removal of sutures|Diagnosis|N/A|\N|
|166567|Sand flea infestation|Diagnosis|N/A|\N|
|166567|Tunga penetrans infestation|Diagnosis|N/A|\N|
|166567|Tungiasis|Diagnosis|N/A|\N|
|166567|Jiggers|Diagnosis|N/A|\N|
|166566|Date of weaning|Question|Date|\N|
|166566|Date child fully weaned|Question|Date|\N|
|166565|Weaning speed|Question|Coded|The speed that the mother weans the child off breastfeeding.|
|166564|Hx bleeding|Finding|N/A|\N|
|166564|Personal history of bleeding|Finding|N/A|\N|
|166564|History of bleeding|Finding|N/A|\N|
|166564|History of hemorrhage|Finding|N/A|\N|
|166563|HIV exposed infant program|Program|N/A|\N|
|166562|Infection due to C.37 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
|166562|Infection due to Lamda variant COVID-19|Diagnosis|N/A|\N|
|166562|Infection due to Peru variant COVID-19|Diagnosis|N/A|\N|
|166562|Infection due to COVID-19 C.37|Diagnosis|N/A|\N|
|166561|C.37 variant|Misc|N/A|\N|
|166561|Lamda variant|Misc|N/A|\N|
|166561|Peru variant|Misc|N/A|\N|
|166560|Biopsy of endocervix|Procedure|N/A|\N|
|166559|Had sexual activity with broken condom|Question|Coded|\N|
|166559|Had sexual activity with burst condom|Question|Coded|\N|
|166558|Partner disease treatment monitoring construct|ConvSet|N/A|\N|
|166557|Disease treatment monitoring construct|ConvSet|N/A|\N|
|166556|Cryptococcal ag test, CSF|Test|Coded|\N|
|166556|Cerebrospinal fluid Cryptococcus antigen assay|Test|Coded|\N|
|166556|Cryptococcal antigen test, CSF|Test|Coded|\N|
|166555|Blood Cryptococcus species antigen assay|Test|Coded|\N|
|166555|Cryptococcal ag test|Test|Coded|\N|
|166555|Cryptococcal antigen test, blood|Test|Coded|\N|
|166554|Vibrio cholerae|Organism|N/A|\N|
|166553|Haemophilus parainfluenzae|Organism|N/A|\N|
|166552|Pseudomonas|Organism|N/A|Genus of organism|
|166551|Avibactam / ceftazidime|Drug|N/A|\N|
|166551|Avycaz|Drug|N/A|\N|
|166550|Antimicrobial drug sensitivity test|Test|N/A|\N|
|166550|Antimicrobial susceptibility test|Test|N/A|\N|
|166550|Antibiotic susceptibility test|Test|N/A|\N|
|166549|Type of organism, non-coded (text)|Question|Text|\N|
|166548|Sensitive to antimicrobial|Finding|N/A|\N|
|166548|Not resistant to antimicrobial|Finding|N/A|\N|
|166547|Intermediate resistant to antimicrobial|Finding|N/A|\N|
|166546|Resistant to antimicrobial|Finding|N/A|\N|
|166545|Resistance level of organism against antimicrobial|Question|Coded|\N|
|166544|Antibiotic tested|Question|Coded|Name of the antimicrobial used for testing|
|166543|Type of organism|Question|Coded|Species of organism|
|166542|Recurrent sex under influence of alcohol|Finding|N/A|\N|
|166541|Reason for negative contact tracing outcome|Question|Coded|\N|
|166541|Reason for failed contact tracing|Question|Coded|\N|
|166540|Contact locations details incorrect|Finding|N/A|\N|
|166540|Contact locations details inaccurate|Finding|N/A|\N|
|166539|Contact details inaccurate|Finding|N/A|\N|
|166539|Contact details incorrect|Finding|N/A|\N|
|166538|Contact location details missing|Finding|N/A|\N|
|166537|Contact details missing|Finding|N/A|Contact name, phone, etc. not available|
|166536|Pre-exposure prophylaxis (PrEP)|Procedure|N/A|\N|
|166535|Pre-exposure prophylaxis (PrEP) status|Question|Coded|\N|
|166534|Eligible for pre-exposure prophylaxis (PrEP)|Finding|N/A|\N|
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for October 12, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for KenyaEMR, MSF, PIH and COVID-19 (including new concepts for the antiviral drug and anti-malarial vaccine. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
"concept_id" "name" "Class" "Datatype" "description" "166839" "Tendon transfer" "Procedure" "N/A" \N "166838" "Tendon release" "Procedure" "N/A" \N "166837" "Tendon graft procedure" "Procedure" "N/A" \N "166837" "Tendon grafting" "Procedure" "N/A" \N "166836" "Surgical extraction of tooth" "Procedure" "N/A" \N "166835" "Trephination of cranium" "Procedure" "N/A" \N "166835" "Creation of cranial burr hole" "Procedure" "N/A" \N "166834" "Total ureterectomy" "Procedure" "N/A" \N "166833" "Partial ureterectomy" "Procedure" "N/A" \N "166832" "Gynecological examination" "Procedure" "N/A" \N "166832" "GYN exam" "Procedure" "N/A" \N "166832" "Gynaecological examination" "Procedure" "N/A" \N "166831" "Para-aortic lymphadenectomy" "Procedure" "N/A" \N "166830" "Pelvic lymphadenectomy" "Procedure" "N/A" \N "166829" "Transverse abdominis plane block" "Procedure" "N/A" "Type of peripheral nerve block" "166829" "Transverse abdominis plane (TAP) anesthesia" "Procedure" "N/A" "Type of peripheral nerve block" "166828" "Lymph node ultrasound findings (coded)" "Question" "Coded" \N "166827" "Para-aortic adenopathy" "Finding" "N/A" \N "166827" "Para-aortic lymphadenopathy" "Finding" "N/A" \N "166826" "Bilateral pelvic lymphadenopathy" "Finding" "N/A" \N "166826" "Bilateral pelvic adenopathy" "Finding" "N/A" \N "166825" "Right pelvic lymphadenopathy" "Finding" "N/A" \N "166825" "Right pelvic adenopathy" "Finding" "N/A" \N "166824" "Left pelvic lymphadenopathy" "Finding" "N/A" \N "166824" "Left pelvic adenopathy" "Finding" "N/A" \N "166823" "Renal ultrasound findings (coded)" "Question" "Coded" \N "166822" "Ureter width maximum measurement (mm)" "Question" "Numeric" \N "166822" "Ureter maximum diameter (mm)" "Question" "Numeric" \N "166821" "Stage 1B3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166821" "Stage IB3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166820" "Stage IB2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166820" "Stage 1B2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166819" "Stage IB1" "Misc" "N/A" "" "166819" "Stage IB1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166818" "Endometrial biopsy curette" "Medical supply" "N/A" \N "166817" "New York Heart Association Classification class" "Question" "Coded" \N "166816" "Stage IIIC2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166816" "Stage 3C2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166815" "Stage IIIC1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166815" "Stage 3C1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166814" "Stage IIA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166814" "Stage 2A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166813" "Stage IIA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166813" "Stage 2A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166812" "Stage 1A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166812" "Stage IA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166811" "Stage 1A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166811" "Stage IA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer." "166810" "Full code status" "Finding" "N/A" \N "166810" "For resuscitation" "Finding" "N/A" \N "166809" "Do not intubate (DNI)" "Finding" "N/A" \N "166809" "DNAI" "Finding" "N/A" \N "166809" "Do not attempt intubation" "Finding" "N/A" \N "166808" "Chemical code only" "Finding" "N/A" \N "166808" "Medication code only" "Finding" "N/A" \N "166807" "Resuscitation status" "Question" "Coded" \N "166807" "Advance care plan details" "Question" "Coded" \N "166807" "Advance directives" "Question" "Coded" \N "166806" "Pelvic ultrasound done" "Question" "Coded" \N "166806" "Pelvic ultrasound carried out" "Question" "Coded" \N "166806" "Pelvic ultrasound performed" "Question" "Coded" \N "166805" "International Ovarian Tumor Analysis classification malignant features" "Question" "Coded" \N "166805" "IOTA M-features" "Question" "Coded" \N "166804" "International Ovarian Tumor Analysis classification benign features" "Question" "Coded" \N "166804" "IOTA B-features" "Question" "Coded" \N "166803" "Not involved" "Misc" "N/A" "General descriptor" "166803" "Uninvolved" "Misc" "N/A" "General descriptor" "166802" "Involved" "Misc" "N/A" "General descriptor" "166801" "Parametrial involvement" "Question" "Coded" \N "166801" "Parametrial invasion" "Question" "Coded" \N "166800" "Right ovary length (mm)" "Question" "Numeric" \N "166800" "Right ovary longitudinal measurement (mm)" "Question" "Numeric" \N "166799" "Left ovary longitudinal measurement (mm)" "Question" "Numeric" \N "166799" "Left ovary length (mm)" "Question" "Numeric" \N "166798" "Tumour largest measurement (mm)" "Finding" "Numeric" \N "166798" "Tumor maximum dimension (mm)" "Finding" "Numeric" \N "166797" "Application of skin graft" "Procedure" "N/A" \N "166796" "Skin flap operation" "Procedure" "N/A" \N "166795" "Removal, fingernail or toenail" "Procedure" "N/A" \N "166795" "Removal of nail of digit" "Procedure" "N/A" \N "166794" "Removal of external fixation pin" "Procedure" "N/A" \N "166793" "Removal of external fixation device" "Procedure" "N/A" \N "166792" "Harvest of axial pattern flap of skin" "Procedure" "N/A" \N "166791" "Reconstruction with local flap" "Procedure" "N/A" \N "166790" "Reconstruction procedure" "Procedure" "N/A" \N "166789" "Position of kidney" "Question" "Coded" \N "166788" "Very strong blood flow" "Finding" "N/A" \N "166787" "Smooth multilocular tumor with largest diameter greater than 100 mm" "Finding" "N/A" \N "166787" "Smooth multilocular tumor with largest diameter > 100 mm" "Finding" "N/A" \N "166786" "At least 4 papillary structures" "Finding" "N/A" \N "166786" "At least four papillary structures present" "Finding" "N/A" \N "166785" "Ascites present on ultrasound" "Question" "Coded" \N "166784" "Irregular solid tumor" "Misc" "N/A" \N "166783" "No blood flow" "Finding" "N/A" \N "166783" "Blood flow absent" "Finding" "N/A" \N "166782" "Smooth multilocular tumor with largest diameter less than 100 mm" "Finding" "N/A" \N "166782" "Smooth multilocular tumor with largest diameter < 100 mm" "Finding" "N/A" \N "166781" "Presence of acoustic shadows" "Finding" "N/A" \N "166780" "Solid components with largest diameter < 7 mm" "Finding" "N/A" \N "166779" "Unilocular" "Misc" "N/A" "General descriptor" "166778" "Malignant" "Misc" "N/A" "General descriptor" "166777" "Benign" "Misc" "N/A" "General description" "166776" "IOTA classification" "Question" "Coded" \N "166776" "International Ovarian Tumor Analysis (IOTA) group ultrasound category" "Question" "Coded" \N "166775" "Right ovary description (text)" "Question" "Text" \N "166774" "Left ovary description (text)" "Question" "Text" \N "166773" "Left ovary longitudinal diameter (mm)" "Question" "Numeric" \N "166773" "Left ovary longitudinal measurement (mm)" "Question" "Numeric" \N "166772" "Right ovary appearance" "Question" "Coded" \N "166771" "Left ovary appearance" "Question" "Coded" \N "166770" "Vascularized" "Misc" "N/A" "General descriptor" "166770" "Vascular" "Misc" "N/A" "General descriptor" "166769" "Heterogeneous" "Misc" "N/A" "General descriptor" "166768" "Hypoechogenic" "Misc" "N/A" "General descriptor of appearance on ultrasound" "166768" "Hypoechoic" "Misc" "N/A" "General descriptor of appearance on ultrasound" "166767" "Solid" "Misc" "N/A" "General descriptor" "166766" "Cervical tumor characterization via ultrasound" "Question" "Coded" \N "166765" "Uterus, other finding on ultrasound" "Question" "Text" \N "166764" "Endometrial thickness by ultrasound (mm)" "Question" "Numeric" \N "166764" "Endometrial thickness (mm)" "Question" "Numeric" \N "166763" "Uterus size, transverse diameter (mm)" "Question" "Numeric" \N "166763" "Uterus size, transverse measurement (mm)" "Question" "Numeric" \N "166762" "Uterus size, anteroposterior measurement (mm)" "Question" "Numeric" \N "166762" "Uterus size, anteroposterior diameter (mm)" "Question" "Numeric" \N "166761" "Uterus size, longitudinal diameter (mm)" "Question" "Numeric" \N "166761" "Uterus size, longitudinal measurement (mm)" "Question" "Numeric" \N "166760" "Procurement of skin and subcutaneous tissue for graft or flap" "Procedure" "N/A" \N "166759" "Release of contracture of scar" "Procedure" "N/A" \N "166758" "Quadriceplasty" "Procedure" "N/A" \N "166757" "Prosthetic dental implant" "Procedure" "N/A" \N "166757" "Implantation of dental prosthesis" "Procedure" "N/A" \N "166756" "Posteromedial tendon release of clubfoot" "Procedure" "N/A" \N "166756" "Posteromedial release of calcaneotalar equinovarus" "Procedure" "N/A" \N "166755" "Peripheral nerve neurolysis" "Procedure" "N/A" \N "166754" "Paranasal sinusectomy" "Procedure" "N/A" \N "166753" "Skeletal traction" "Procedure" "N/A" \N "166752" "Osteotomy" "Procedure" "N/A" \N "166751" "Open biopsy soft tissue" "Procedure" "N/A" \N "166750" "Nerve graft" "Procedure" "N/A" \N "166749" "Manipulation under anesthesia" "Procedure" "N/A" \N "166748" "Lysis of adhesions of tendon" "Procedure" "N/A" \N "166748" "Tenolysis" "Procedure" "N/A" \N "166747" "Local subcutaneous pedicled V-Y flap" "Procedure" "N/A" \N "166746" "Local rotation flap" "Procedure" "N/A" \N "166745" "Reconstruction of ligament" "Procedure" "N/A" \N "166744" "Capsulodesis of joint" "Procedure" "N/A" \N "166744" "Capsulodesis" "Procedure" "N/A" \N "166743" "Insertion of intramedullary rod" "Procedure" "N/A" \N "166743" "Internal fixation using intramedullary nail" "Procedure" "N/A" \N "166742" "Application of bioengineered skin graft" "Procedure" "N/A" \N "166742" "Application of biosynthetic skin graft" "Procedure" "N/A" \N "166741" "Injection of steroid into joint" "Procedure" "N/A" \N "166741" "Intra-articular steroid injection" "Procedure" "N/A" \N "166740" "Application of McGregor groin flap" "Procedure" "N/A" \N "166740" "Application of iliofemoral groin flap" "Procedure" "N/A" \N "166739" "Fixation of fracture using pins" "Procedure" "N/A" \N "166738" "Filling of segmental defect by bone transport" "Procedure" "N/A" \N "166737" "Fascial sling for facial weakness" "Procedure" "N/A" \N "166736" "Exploration of nerve" "Procedure" "N/A" \N "166735" "Lengthening of Achilles tendon" "Procedure" "N/A" \N "166735" "Elongation of tendo achilles" "Procedure" "N/A" \N [9:28](https://openmrs.slack.com/archives/D012KKH9G8P/p1634092092000600) "166734" "Epiphysiodesis" "Procedure" "N/A" \N "166733" "Dynamization of external fixator" "Misc" "N/A" \N "166733" "Dynamisation of external fixator" "Misc" "N/A" \N "166732" "Division of flap" "Procedure" "N/A" \N "166731" "Removal of K-wire" "Procedure" "N/A" \N "166731" "Removal of Kirschner wire" "Procedure" "N/A" \N "166730" "Removal of plate from bone" "Procedure" "N/A" \N "166729" "Removal of bone screw" "Procedure" "N/A" \N "166728" "Removal of skin suture or clip" "Procedure" "N/A" \N "166727" "Removal of tissue expander" "Procedure" "N/A" \N "166726" "Tenorrhaphy" "Procedure" "N/A" \N "166726" "Repair of tendon" "Procedure" "N/A" \N "166725" "Revision of amputation stump" "Procedure" "N/A" \N "166724" "Revision of scar" "Procedure" "N/A" \N "166723" "Surgical removal of sequestrum" "Procedure" "N/A" \N "166723" "Sequestrectomy" "Procedure" "N/A" \N "166722" "Maxillary sinusectomy" "Procedure" "N/A" \N "166722" "Sinusectomy, maxillary" "Procedure" "N/A" \N "166721" "Radical vaginal hysterectomy" "Procedure" "N/A" \N "166720" "Radical trachelectomy" "Procedure" "N/A" \N "166719" "Partial vulvectomy" "Procedure" "N/A" \N "166718" "Total vulvectomy" "Procedure" "N/A" \N "166717" "Partial colectomy" "Procedure" "N/A" \N "166717" "Partial vaginectomy" "Procedure" "N/A" \N "166716" "Total colpectomy" "Procedure" "N/A" \N "166716" "Total vaginectomy" "Procedure" "N/A" \N "166715" "Incision and drainage" "Procedure" "N/A" \N "166714" "Dermabrasion" "Procedure" "N/A" \N "166713" "Oral commisuroplasty" "Procedure" "N/A" \N "166712" "Surgical removal of coronoid process of mandible" "Procedure" "N/A" \N "166712" "Coronoidectomy" "Procedure" "N/A" \N "166711" "Adjustment of external fixation device" "Procedure" "N/A" \N "166710" "Change of external fixation device" "Procedure" "N/A" \N "166710" "Replacement of external fixation device" "Procedure" "N/A" \N "166709" "Capsulectomy" "Procedure" "N/A" \N "166708" "Bone lengthening" "Procedure" "N/A" \N "166707" "Local anesthesia by infiltration" "Procedure" "N/A" \N "166706" "Thermocoagulation of cervix" "Procedure" "N/A" \N "166706" "Thermocauterization of cervix" "Procedure" "N/A" \N "166705" "Next consultation to be scheduled (text)" "Question" "Text" \N "166704" "Normal breastfeeding" "Finding" "N/A" \N "166703" "Malaria vaccine" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline" "166703" "Mosquirix" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline" "166703" "RTS,S/AS01 vaccine" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline" "166702" "VIR-7831" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline" "166702" "GSK4182136" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline" "166702" "Sotrovimab" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline" "166701" "P.2 variant" "Misc" "N/A" \N "166701" "Zeta variant" "Misc" "N/A" \N "166700" "Molnupiravir" "Drug" "N/A" \N "166700" "Mjölnir" "Drug" "N/A" \N "166700" "MK-4482" "Drug" "N/A" \N "166699" "Impossible to evaluate" "Misc" "N/A" \N "166699" "Cannot be determined" "Misc" "N/A" \N "166698" "Fluid specimen from wound" "Misc" "N/A" \N "166697" "Specimen from soft tissue" "Misc" "N/A" \N "166696" "Negative-pressure wound therapy system pump" "Medical supply" "N/A" \N "166695" "Penrose drain" "Medical supply" "N/A" \N "166694" "Bone specimen" "Misc" "N/A" \N "166694" "Sample from bone" "Misc" "N/A" \N "166693" "Type of drain" "Question" "Coded" \N "166692" "Anesthetic nurse name" "Question" "Text" \N "166692" "Anesthesia nurse name" "Question" "Text" \N "166691" "Circulating nurse name" "Question" "Text" \N "166690" "Scrub nurse name" "Question" "Text" \N "166690" "OR nurse name" "Question" "Text" \N "166690" "Operating theater nurse name" "Question" "Text" \N "166690" "OT nurse name" "Question" "Text" \N "166689" "Anesthesiologist name" "Question" "Text" \N "166689" "Anesthetist name" "Question" "Text" \N "166688" "Surgeon name" "Question" "Text" \N "166687" "Darunavir / Dolutegravir / Efavirenz / Lamivudine / Ritonavir / Tenofovir" "Misc" "N/A" "Antiretroviral regimen" "166686" "Abacavir / Lamivudine / Raltegravir" "Misc" "N/A" "Antiretroviral regimen" "166685" "Darunavir / Lamivudine / Raltegravir / Ritonavir / Zidovudine" "Misc" "N/A" "Antiretroviral regimen" "166684" "Darunavir / Lamivudine / Raltegravir / Ritonavir / Zidovudine" "Misc" "N/A" "Antiretroviral regimen" "166683" "Abacavir / Darunavir / Lamivudine / Raltegravir / Ritonavir" "Misc" "N/A" "Antiretroviral Regimen" "166682" "Frequency of prior night amnesia over past year" "Question" "Coded" "CAPTION: How often during the last year have you been unable to remember what happened the night before because you had been drinking" "166681" "Frequency of feeling guilty or remorse about drinking over past year" "Question" "Coded" \N "166680" "Drank alcohol prior to current year only" "Question" "Coded" \N "166679" "Drank alcohol in current year" "Question" "Coded" \N "166678" "Number of alcoholic drinks consumed per day" "Question" "Numeric" \N "166677" "Male circumcision status" "Question" "Coded" \N "166676" "Behavioural risk assessment outcome" "Question" "Coded" \N "166676" "Behavioral risk assessment outcome" "Question" "Coded" \N "166675" "Low risk" "Misc" "N/A" "General modifier characterizing low risk" "166674" "High risk" "Misc" "N/A" "General modifier characterizing high risk" "166673" "Severe major depression" "Diagnosis" "N/A" \N "166672" "Severe recurrent major depression" "Diagnosis" "N/A" \N "166671" "Discussion about risk reduction" "Question" "Text" \N "166670" "Contraindications for pre exposure prophylaxis (PrEP)" "Question" "Coded" \N "166669" "Mu variant" "Misc" "N/A" \N "166669" "B.1.621 variant" "Misc" "N/A" \N "166668" "Kappa variant" "Misc" "N/A" \N "166668" "B.1.617.1 variant" "Misc" "N/A" \N "166667" "B.1.526 variant" "Misc" "N/A" \N "166667" "Iota variant" "Misc" "N/A" \N "166666" "B.1.525 variant" "Misc" "N/A" \N "166666" "Eta variant" "Misc" "N/A" \N "166665" "Treatment given" "Question" "Coded" \N "166664" "Result of screening procedure" "Finding" "Coded" \N "166664" "Screening result" "Finding" "Coded" \N "166663" "Screening performed" "Question" "Coded" \N "166662" "Disease or focus of screening" "Question" "Coded" \N "166661" "Screening construct" "ConvSet" "N/A" \N "166660" "COVID-19 booster vaccination" "Procedure" "N/A" \N "166660" "COVID-19 booster shot" "Procedure" "N/A" \N "166660" "COVID-19 booster immunization" "Procedure" "N/A" \N "166660" "Administration of booster severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine" "Procedure" "N/A" \N "166659" "Underlying cause of death" "Question" "Boolean" "The original underlying cause of death in a sequence of causes usually derived from the last cause of death in section I of the WHO death certificate" "166658" "Previous sex without condom" "Question" "Coded" \N "166658" "Had sex without condom" "Question" "Coded" \N "166657" "Willing to take pre-exposure prophylaxis (PrEP)" "Question" "Coded" \N "166656" "Referred for preventative services" "Finding" "Coded" \N "166655" "Pre-exposure prophylaxis (PrEP) plan" "Question" "Coded" \N "166655" "Pre-exposure prophylaxis (PrEP) regimen" "Question" "Coded" \N
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for December 15, 2021!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for MSF, PIH and COVID-19 (including new concepts for more international vaccines). Please update your dictionaries. This release also had some clean-up to ensure that it complies to more recent OMRS validation scripts. That means some duplicate names were removed and some duplicate concepts were retired.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
"concept_id" "name" "Class" "Datatype" "description"
"167023" "Left ventricular systolic function" "Question" "Coded" \N
"167023" "Left ventricular ejection fraction" "Question" "Coded" \N
"167022" "Guardian understands patient's disease and prognosis" "Question" "Coded" \N
"167021" "Patient understands their disease and prognosis" "Question" "Coded" \N
"167020" "Precancerous lesion histological grade (text)" "Question" "Text" \N
"167019" "Precancerous cervical lesion histological grade" "Question" "Coded" \N
"167018" "Name of person attending with patient" "Question" "Text" \N
"167017" "Follow-up period" "Question" "Coded" \N
"167016" "12 month follow-up" "Procedure" "N/A" \N
"167016" "Yearly follow-up" "Procedure" "N/A" \N
"167016" "Twelve month follow-up" "Procedure" "N/A" \N
"167015" "Six month follow-up" "Procedure" "N/A" \N
"167015" "6 month follow-up" "Procedure" "N/A" \N
"167014" "4 month follow-up" "Procedure" "N/A" \N
"167014" "Four month follow-up" "Procedure" "N/A" \N
"167013" "3 month follow-up" "Procedure" "N/A" \N
"167013" "Three month follow-up" "Procedure" "N/A" \N
"167012" "2 month follow-up" "Procedure" "N/A" \N
"167012" "Two month follow-up" "Procedure" "N/A" \N
"167011" "Status of call attempt" "Question" "Coded" \N
"167010" "Patient/Guardian tried to contact care team within 14 days of death" "Question" "Coded" \N
"167009" "Patient condition the day before death" "Question" "Coded" \N
"167008" "Patient condition a week before death" "Question" "Coded" \N
"167007" "Feeling down, depressed, or hopeless over past two weeks" "Question" "Coded" \N
"167006" "Little interest or pleasure in doing things over past two weeks" "Question" "Coded" \N
"167005" "Not being able to stop or control worrying over past two weeks" "Question" "Coded" \N
"167004" "Rapid assessment" "Procedure" "N/A" \N
"167003" "Feeling nervous, anxious or on edge over past two weeks" "Question" "Coded" \N
"167002" "Nearly every day" "Misc" "N/A" \N
"167001" "More than half the days" "Misc" "N/A" \N
"167000" "Several days" "Misc" "N/A" \N
"166999" "Ascites severity grade" "Question" "Coded" \N
"166998" "Norton pressure ulcer risk score" "Question" "Numeric" \N
"166997" "Telehealth consultation" "Procedure" "N/A" \N
"166997" "Telehealth visit" "Procedure" "N/A" \N
"166997" "Telemedicine consultation" "Procedure" "N/A" \N
"166996" "Village chief" "Misc" "N/A" \N
"166995" "Successful" "Misc" "N/A" \N
"166994" "Unsuccessful" "Misc" "N/A" \N
"166993" "General inhalation anesthesia using laryngeal mask" "Procedure" "N/A" \N
"166993" "GAL" "Procedure" "N/A" \N
"166992" "Uterine conservation surgery" "Procedure" "N/A" "Procedure for cervical excision which preserves the uterus such as LEEP, conization, trachelectomy"
"166991" "Intravenous induction of general anesthesia" "Procedure" "N/A" \N
"166990" "Type of death/grief support provided" "Question" "Coded" \N
"166989" "Grade 3" "Misc" "N/A" \N
"166989" "Grade III" "Misc" "N/A" \N
"166988" "Grade 2" "Misc" "N/A" \N
"166988" "Grade II" "Misc" "N/A" \N
"166987" "Grade I" "Misc" "N/A" \N
"166987" "Grade 1" "Misc" "N/A" \N
"166986" "Bedside oral exam (BOE) score" "Question" "Numeric" \N
"166985" "Patient died peacefully" "Question" "Coded" \N
"166985" "Patient died comfortably" "Question" "Coded" \N
"166984" "Care team/provider responsive to patient needs" "Question" "Coded" \N
"166984" "Would you say that the team has responded to the patient’s needs" "Question" "Coded" \N
"166983" "Care team/provider responsive to family/guardian needs" "Question" "Coded" \N
"166983" "Would you say that the team has responded to your needs" "Question" "Coded" \N
"166982" "Would you say that the team gave you enough information about the patient’s conditions" "Question" "Coded"\N
"166982" "Sufficiently informed about patient status" "Question" "Coded" \N
"166982" "Sufficiently informed about patient condition" "Question" "Coded" \N
"166981" "Would you say that this experience caused financial stress" "Question" "Coded" \N
"166981" "Financial stress due to experience" "Question" "Coded" \N
"166980" "Would you say that you were stressed from this experience" "Question" "Coded" \N
"166980" "Stressed by experience" "Question" "Coded" \N
"166979" "Would you say that you were tired from this experience" "Question" "Coded" \N
"166979" "Experience tiring" "Question" "Coded" \N
"166978" "Was death expected" "Question" "Coded" \N
"166978" "Death expected" "Question" "Coded" \N
"166977" "Definitely not" "Misc" "N/A" \N
"166976" "Probably not" "Misc" "N/A" \N
"166975" "Reason for failed call" "Question" "Text" \N
"166975" "Reason for unsuccessful call" "Question" "Text" \N
"166975" "Reason for unsuccessful telephone call" "Question" "Text" \N
"166974" "Reason for telephone call" "Question" "Text" \N
"166974" "Reason for phone contact" "Question" "Text" \N
"166974" "Reason for call" "Question" "Text" \N
"166973" "Legal guardian name" "Question" "Text" \N
"166972" "Reason out of medication" "Question" "Text" \N
"166972" "Reason for drug stock out" "Question" "Text" \N
"166971" "Has the patient lacked in stock of drugs in the last 14 days before death" "Question" "Coded" \N
"166971" "Patient ran out of medication within 14 days of death" "Question" "Coded" \N
"166970" "Was the patient admitted to any health facility in the last 14 days before death" "Question" "Coded" \N
"166970" "Death within 14 days of admission to a health facility" "Question" "Coded" \N
"166969" "Location of death (text)" "Question" "Text" \N
"166969" "Place of death (text)" "Question" "Text" \N
"166968" "Place of death" "Question" "Coded" \N
"166968" "Location of death" "Question" "Coded" \N
"166967" "Decubitus ulcer staging" "Question" "Coded" \N
"166967" "Bed sore wound staging" "Question" "Coded" \N
"166967" "Pressure ulcer staging" "Question" "Coded" \N
"166966" "Total radical vulvectomy" "Procedure" "N/A" \N
"166966" "Radical total vulvectomy" "Procedure" "N/A" \N
"166965" "Total vaginal hysterectomy" "Procedure" "N/A" \N
"166964" "Intramuscular administration of ZyCoV-D COVID-19 vaccine" "Procedure" "N/A" \N
"166963" "Cadila Healthcare ZyCov-D COVID-19 vaccine" "Drug" "N/A" \N
"166962" "Intramuscular administration of Soberana-02 COVID-19 vaccine" "Procedure" "N/A" \N
"166961" "FINLAY-FR-1A" "Drug" "N/A" \N
"166961" "Soberana-02 COVID-19 Vaccine" "Drug" "N/A" \N
"166960" "Intramuscular administration of Gamaleya Sputnik Light COVID-19 vaccine" "Procedure" "N/A" \N
"166959" "Gamaleya Sputnik Light COVID-19 vaccine" "Drug" "N/A" "Single dose vaccine based on recombinant adenovirus type 26 (rAd26) vector carrying the gene for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein"
"166958" "Intramuscular administration of COVIran COVID-19 vaccine" "Procedure" "N/A" \N
"166957" "COVIran Barekat COVID-19 vaccine" "Drug" "N/A" \N
"166956" "Intramuscular administration of KCONVAC vaccine" "Procedure" "N/A" \N
"166956" "Intramuscular administration of Minhai COVID-19 vaccine" "Procedure" "N/A" \N
"166955" "Intramuscular administration of QazVac COVID-19 vaccine" "Procedure" "N/A" \N
"166955" "Intramuscular administration of QazCovid-in COVID-19 vaccine" "Procedure" "N/A" \N
"166954" "QazVac" "Drug" "N/A" "COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan."
"166954" "QazCovid-in COVID-19 vaccine" "Drug" "N/A" "COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan."
"166953" "Minhai COVID-19 vaccine" "Drug" "N/A" \N
"166953" "KCONVAC" "Drug" "N/A" \N
"166952" "Left ventricular volume estimated from ultrasound (qualitative)" "Question" "Coded" \N
"166951" "Impaired wound healing" "Finding" "N/A" \N
"166950" "Inferior vena cava findings" "Question" "Coded" \N
"166949" "Moderately dilated inferior vena cava" "Finding" "N/A" \N
"166948" "Severely dilated inferior vena cava" "Finding" "N/A" \N
"166947" "Pericardium findings" "Question" "Coded" \N
"166946" "No pericardial effusion" "Finding" "N/A" \N
"166945" "Minimal pericardial effusion" "Finding" "N/A" \N
"166945" "Mild pericardial effusion" "Finding" "N/A" \N
"166944" "Moderate pericardial effusion" "Finding" "N/A" \N
"166943" "Severe pericardial effusion" "Finding" "N/A" \N
"166942" "Malignancy status" "Question" "Coded" "The status or classification of potential malignancy from benign to confirmed malignancy."
"166941" "Thoracic drainage, closed" "Procedure" "N/A" \N
"166941" "Closed drainage of chest" "Procedure" "N/A" \N
"166940" "Mitral valve findings" "Question" "Coded" \N
"166939" "Corrective osteotomy" "Procedure" "N/A" \N
"166938" "Patient referred to palliative care" "Question" "Coded" \N
"166937" "Care management plan" "Question" "Coded" "Patient's coded care management plan"
"166936" "Atypical behaviour due to pain" "Finding" "N/A" \N
"166936" "Atypical behavior due to pain" "Finding" "N/A" \N
"166935" "ALGOPLUS pain assessment findings" "Question" "Coded" \N
"166934" "Complaints due to pain" "Finding" "N/A" \N
"166933" "Look due to pain" "Finding" "N/A" \N
"166933" "Appearance due to pain" "Finding" "N/A" \N
"166932" "Facial expression due to pain" "Finding" "N/A" "Person shows facial expressions due to pain."
"166931" "Iatrogenic fracture during procedure" "Diagnosis" "N/A" \N
"166931" "Fracture complicating procedure" "Diagnosis" "N/A" \N
"166930" "Chronic nociceptive pain" "Diagnosis" "N/A" \N
"166929" "Right ovary perpendicular dimension (mm)" "Question" "Numeric" \N
"166929" "Right ovary thickness (mm)" "Question" "Numeric" \N
"166928" "Left ovary perpendicular dimension (mm)" "Question" "Numeric" \N
"166928" "Left ovary thickness (mm)" "Question" "Numeric" \N
"166927" "Right ovary hilum-cortex diameter (mm)" "Question" "Numeric" \N
"166926" "Left ovary hilum-cortex diameter (mm)" "Question" "Numeric" \N
"166925" "Chemotherapy type" "Question" "Coded" \N
"166924" "Laparotomy for staging of ovarian cancer" "Procedure" "N/A" \N
"166923" "Total bilateral salpingectomy" "Procedure" "N/A" \N
"166922" "Lymph node dissection" "Procedure" "N/A" \N
"166921" "Wide local excision of vulva" "Procedure" "N/A" \N
"166920" "Palliative chemotherapy" "Procedure" "N/A" \N
"166919" "Adjuvant chemotherapy" "Procedure" "N/A" \N
"166918" "NAC (neo-adjuvant chemotherapy)" "Procedure" "N/A" \N
"166918" "Neo-adjuvant chemotherapy" "Procedure" "N/A" \N
"166917" "Chemotherapy" "Procedure" "N/A" \N
"166916" "GAI" "Procedure" "N/A" \N
"166916" "Endotracheal anesthesia" "Procedure" "N/A" \N
"166916" "Administration of general anesthesia using endotracheal tube" "Procedure" "N/A" \N
"166915" "Open reduction of fracture of bone and internal fixation using wire" "Procedure" "N/A" \N
"166914" "Closed reduction of fracture of bone and internal fixation using wire" "Procedure" "N/A" \N
"166913" "Open reduction of fracture of bone and internal fixation using screw" "Procedure" "N/A" \N
"166912" "Closed reduction of fracture of bone and internal fixation using screw" "Procedure" "N/A" \N
"166911" "Open reduction of fracture and internal fixation with plate" "Procedure" "N/A" \N
"166910" "Closed internal fixation using plate" "Procedure" "N/A" \N
"166910" "Closed reduction of fracture of bone and internal fixation using bone plate" "Procedure" "N/A" \N
"166909" "Adequate" "Misc" "N/A" \N
"166908" "Stage IC3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166908" "Stage 1C3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166907" "Stage IC2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166907" "Stage 1C2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166906" "Stage 1C1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166906" "Stage IC1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166905" "Stage 4A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166905" "Stage IVA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166904" "Stage 4A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166904" "Stage IVA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166903" "Stage 3B2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166903" "Stage IIIB2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166902" "Stage IIIB1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166902" "Stage 3B1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166901" "Stage 3A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166901" "Stage IIIA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166900" "Stage 3A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166900" "Stage IIIA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166899" "Suction drain" "Medical supply" "N/A" \N
"166898" "Suspected stenosis of heart valve" "Finding" "N/A" \N
"166897" "Omicron variant" "Misc" "N/A" \N
"166897" "" "Misc" "N/A" \N
"166897" "B.1.1.529 variant" "Misc" "N/A" \N
"166896" "Number of vaginal pads used per time" "ConvSet" "N/A" \N
"166895" "Number of vaginal pads used" "Question" "Numeric" \N
"166894" "Caesaran section wound healing status" "Question" "Coded" \N
"166893" "C/S scar" "Finding" "N/A" \N
"166893" "Abdominal scar indicative of prior caesarean section" "Finding" "N/A" \N
"166893" "Prior c-section scar" "Finding" "N/A" \N
"166892" "Tingling of skin" "Finding" "N/A" \N
"166891" "Neuropathic pain evaluation questionnaire (DN4)" "Question" "Coded" \N
"166890" "Feeling of electric shocks in body" "Finding" "N/A" "Type of dysesthesia where the patient has the sensation of electrical shocks in a part of the body."
"166889" "Q-M classification" "Question" "Coded" \N
"166889" "Querleu Morrow classification" "Question" "Coded" \N
"166888" "Type C2 - Radical hysterectomy without preservation of autonomic nerves" "Misc" "N/A" \N
"166888" "Type C2" "Misc" "N/A" \N
"166887" "Type C1 - Nerve-preserving radical hysterectomy" "Misc" "N/A" \N
"166887" "Type C1" "Misc" "N/A" \N
"166886" "Type B2" "Misc" "N/A" \N
"166886" "Type B2 - Modified radical hysterectomy with a paracervical lymphadenectomy" "Misc" "N/A" \N
"166885" "Type B1 - Modified radical hysterectomy" "Misc" "N/A" \N
"166885" "Type B1" "Misc" "N/A" \N
"166884" "Type A" "Misc" "N/A" \N
"166884" "Type A - Limited Radical Hysterectomy " "Misc" "N/A" \N
"166883" "Pain Verbal Rating Scale (VRS)" "Misc" "N/A" \N
"166882" "Pain Numerical Rating Scale (NRS)" "Misc" "N/A" \N
"166881" "Location of radiating pain" "Question" "Coded" \N
"166881" "Site of pain radiation" "Question" "Coded" \N
"166880" "ALGOPLUS pain scale" "Misc" "N/A" \N
"166880" "ALGOPLUS pain assessment" "Misc" "N/A" \N
"166879" "Pain scale used" "Question" "Coded" \N
"166878" "Pain etiology" "Question" "Coded" \N
"166878" "Cause of pain" "Question" "Coded" \N
"166877" "PF-07321332 / Ritonavir" "Drug" "N/A" \N
"166877" "PAXLOVID" "Drug" "N/A" \N
"166876" "Pinprick hypoesthesia" "Finding" "N/A" \N
"166875" "Pain caused by light brushing of the skin" "Finding" "N/A" \N
"166875" "Cutaneous allodynia to light brushing" "Finding" "N/A" \N
"166874" "Severely enlarged" "Misc" "N/A" \N
"166873" "Moderately enlarged" "Misc" "N/A" \N
"166872" "Mildly enlarged" "Misc" "N/A" \N
"166871" "Right ventricular volume estimated from ultrasound (qualitative)" "Question" "Coded" \N
"166870" "Application of below elbow back slab" "Procedure" "N/A" \N
"166869" "Unintended removal of implant" "Finding" "N/A" \N
"166869" "Accidental removal of implant" "Finding" "N/A" \N
"166868" "Hypodermic needle" "Medical supply" "N/A" \N
"166867" "Commodity dispense construct" "ConvSet" "N/A" \N
"166866" "Commodity name (coded)" "Question" "Coded" \N
"166866" "Supply type" "Question" "Coded" \N
"166866" "Commodity type" "Question" "Coded" \N
"166865" "Date given" "Question" "Date" \N
"166865" "Date distributed" "Question" "Date" \N
"166865" "Date dispensed" "Question" "Date" \N
"166864" "Number dispensed" "Question" "Numeric" \N
"166864" "Quantity distributed" "Question" "Numeric" \N
"166863" "Syringe, disposable" "Medical supply" "N/A" \N
"166862" "Sexual lubricant" "Medical supply" "N/A" \N
"166862" "Lube" "Medical supply" "N/A" \N
"166861" "HIV self-test kit" "Medical supply" "N/A" \N
"166860" "Atypical behaviour due to pain" "Finding" "N/A" \N
"166860" "Body position due to pain" "Finding" "N/A" \N
"166859" "Neuropraxia" "Diagnosis" "N/A" \N
"166858" "Daklinza" "Drug" "N/A" \N
"166858" "Daclatasvir" "Drug" "N/A" \N
"166857" "Oxytrol" "Drug" "N/A" \N
"166857" "Oxybutynin" "Drug" "N/A" \N
"166856" "ASCVD Risk Score" "Question" "Numeric" "The ASCVD (atherosclerotic cardiovascular disease) risk score is a national guideline developed by the American
College of Cardiology. It is a calculation of your 10-year risk of having a cardiovascular problem, such as a heart
attack or stroke. This risk estimate considers age, sex, race, cholesterol levels, blood pressure, medication use,
diabetic status, and smoking status."
"166856" "Atherosclerotic cardiovascular disease risk score" "Question" "Numeric" "The ASCVD (atherosclerotic cardiovascular disease) risk score is a national guideline developed by the American
College of Cardiology. It is a calculation of your 10-year risk of having a cardiovascular problem, such as a heart
attack or stroke. This risk estimate considers age, sex, race, cholesterol levels, blood pressure, medication use,
diabetic status, and smoking status."
"166855" "Literate" "Question" "Coded" \N
"166855" "Able to read and write" "Question" "Coded" \N
"166854" "Minimum pain score" "Question" "Numeric" \N
"166853" "Maximum pain score" "Question" "Numeric" \N
"166852" "Pain site" "Question" "Coded" \N
"166852" "Site of pain" "Question" "Coded" \N
"166851" "Perioperative acute myocardial infarction" "Diagnosis" "N/A" \N
"166850" "Inflammatory pain" "Finding" "N/A" \N
"166849" "Mechanical pain" "Finding" "N/A" \N
"166848" "Date of report" "Question" "Date" \N
"166848" "Report date" "Question" "Date" \N
"166847" "Incident witnessed by" "Question" "Text" \N
"166846" "Incident reported by" "Question" "Text" \N
"166845" "Multisystem inflammatory syndrome in adult (MIS-A) associated with COVID-19" "Diagnosis" "N/A" \N
"166845" "MIS-A associated with COVID-19" "Diagnosis" "N/A" \N
"166845" "Multisystem inflammatory syndrome associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in adult" "Diagnosis" "N/A" \N
"166844" "Touch hypoesthesia" "Finding" "N/A" \N
"166844" "Decreased skin sensation to touch" "Finding" "N/A" \N
"166844" "Tactile hypoaesthesia of skin" "Finding" "N/A" \N
"166844" "Tactile hypesthesia" "Finding" "N/A" \N
"166844" "Tactile hypoesthesia" "Finding" "N/A" \N
"166843" "Break of sterility during operation" "Finding" "N/A" \N
"166843" "Breach of sterile field during procedure" "Finding" "N/A" \N
"166842" "Psychroalgia" "Diagnosis" "N/A" \N
"166842" "Painful feeling of cold" "Diagnosis" "N/A" \N
"166841" "SOF" "Drug" "N/A" \N
"166841" "Sofosbuvir" "Drug" "N/A" \N
"166841" "Sovaldi" "Drug" "N/A" \N
"166840" "Irreversible pulpitis" "Diagnosis" "N/A" \N
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for March 19, 2022!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 and 2.5 are pending but there are no concept table changes.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for MSF, PIH and COVID-19 (including new concepts for more pediatric vaccines). Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release.
> |concept_id|name|Class|Datatype|description|
> |---|---|---|---|---|
> |167164|Very high|Misc|N/A|\N|
> |167163|Algorithmic result (qualitative)|Question|Coded|\N|
> |167162|Algorithmic result (numeric)|Question|Numeric|\N|
> |167161|Victim of gender-based violence in past three months|Question|Coded|\N|
> |167160|Algorithm result|ConvSet|N/A|\N|
> |167159|Suspected cancer|Diagnosis|Coded|\N|
> |167159|Suspected malignant neoplasm|Diagnosis|Coded|\N|
> |167159|Suspected malignancy|Diagnosis|Coded|\N|
> |167158|Telephone number of referring/ordering clinician|Question|Text|\N|
> |167157|Medication dispense status|ConvSet|N/A|http://hl7.org/fhir/CodeSystem/medicationdispense-status|
> |167156|Declined|Misc|N/A|\N|
> |167156|Refused|Misc|N/A|\N|
> |167155|Stopped|Misc|N/A|\N|
> |167155|Discontinued|Misc|N/A|\N|
> |167154|On hold|Misc|N/A|Status for transiently stopping dosing or dispensing a medication or therapy.|
> |167153|Preparation|Misc|N/A|Status of preparing something for an action such as preparing a medication for dispensing.|
> |167152|Provide supplemental oxygen via high flow nasal cannula|Procedure|N/A|\N|
> |167151|Late fetal heart rate deceleration|Finding|N/A|\N|
> |167151|Late foetal heart rate deceleration|Finding|N/A|\N|
> |167150|Duration of ruptured membranes detail|ConvSet|N/A|\N|
> |167149|Duration of ruptured membranes|Question|Numeric|Numeric value to be associated with duration unit (1732)|
> |167148|Duration of labor detail|ConvSet|N/A|\N|
> |167147|Newborn body colour (non-coded)|Question|Text|\N|
> |167147|Neonatal body color (non-coded)|Question|Text|\N|
> |167146|Eligible for testing|Question|Coded|Patient is eligible to be tested.|
> |167145|Experience of sexual or physical violence in past three months|Question|Coded|Within the last 3 months, has the client experienced either physical or sexual violence?|
> |167144|New sexual partner in last three months|Question|Coded|Has the client had a new sexual partner in the last 3 months?|
> |167143|Priority Population|Misc|N/A|\N|
> |167142|Screening tool construct|ConvSet|N/A|\N|
> |167141|Screening tool score|Question|Text|\N|
> |167141|Assessment tool score|Question|Text|\N|
> |167140|Screening tool name (non-coded)|Question|Text|\N|
> |167139|Screening tool name|Question|Coded|\N|
> |167138|Hyper-vigilance|Finding|N/A|\N|
> |167138|Hypervigilant|Finding|N/A|\N|
> |167137|Disorganized thoughts|Diagnosis|N/A|\N|
> |167137|Disorganized thinking|Diagnosis|N/A|\N|
> |167136|Developmental regression in child|Diagnosis|N/A|\N|
> |167135|Repetitious play|Finding|N/A|\N|
> |167135|Repetitive game play|Finding|N/A|\N|
> |167134|Living conditions|Question|Coded|\N|
> |167133|OR ID|Question|Text|\N|
> |167133|Operating theater identification code|Question|Text|\N|
> |167132|Procedure end date/time|Question|Datetime|\N|
> |167131|County of residence|Question|Text|\N|
> |167130|Homeless due to destruction of residence|Finding|N/A|\N|
> |167130|Homeless due to home destroyed|Finding|N/A|\N|
> |167129|Difficulty reasoning|Diagnosis|N/A|\N|
> |167129|Trouble reasoning|Diagnosis|N/A|\N|
> |167128|Avoidance behavior|Diagnosis|N/A|\N|
> |167128|Avoidant behavior|Diagnosis|N/A|\N|
> |167127|Intrusive thoughts|Diagnosis|N/A|\N|
> |167126|Excessive skin removed during circumcision procedure|Finding|N/A|\N|
> |167125|Sexually transmitted disease (STD) treatment|Procedure|N/A|\N|
> |167124|Shang ring|Medical supply|N/A|\N|
> |167123|Forceps guided circumcision|Procedure|N/A|\N|
> |167122|Dorsal slitting of prepuce|Procedure|N/A|\N|
> |167121|Sleeve resection of prepuce|Procedure|N/A|\N|
> |167120|Device circumcision method|Question|Coded|\N|
> |167119|Conventional circumcision method|Question|Coded|\N|
> |167118|Circumcision method|Question|Coded|\N|
> |167117|Homicidal ideation present|Question|Coded|\N|
> |167116|Judgement level|Question|Coded|\N|
> |167116|Judgement|Question|Coded|\N|
> |167115|Insight level|Question|Coded|\N|
> |167114|Denies homicidal ideation|Finding|N/A|\N|
> |167113|Denies suicidal ideation|Finding|N/A|\N|
> |167112|Thought content|Question|Coded|\N|
> |167111|Flight of ideas|Finding|N/A|\N|
> |167110|Tangential thinking|Finding|N/A|\N|
> |167109|Linear thinking|Finding|N/A|\N|
> |167109|Linear thought process|Finding|N/A|\N|
> |167108|Goal oriented|Finding|N/A|\N|
> |167107|Circumferential thought process|Finding|N/A|\N|
> |167107|Circumferential thinking|Finding|N/A|\N|
> |167106|Thought process|Question|Coded|\N|
> |167105|Flat affect|Finding|N/A|\N|
> |167104|Restricted affect|Finding|N/A|\N|
> |167103|Labile affect|Finding|N/A|\N|
> |167102|Normal affect|Finding|N/A|\N|
> |167101|Affect|Question|Coded|\N|
> |167100|Euthymia|Finding|N/A|\N|
> |167100|Euthymic mood|Finding|N/A|\N|
> |167099|Mood|Question|Coded|\N|
> |167098|Road show|Misc|N/A|Presentation or event to communicate information such as a health topic|
> |167097|Social media|Misc|N/A|Facebook, instagram, twitter, etc.|
> |167096|Printed media|Misc|N/A|\N|
> |167096|Newspaper/magazine|Misc|N/A|\N|
> |167095|Broadcast media|Misc|N/A|\N|
> |167095|Radio/Television|Misc|N/A|\N|
> |167094|Source of health information|Question|Coded|\N|
> |167093|Assent given|Question|Coded|Patients unable to give informed consent due to age or disability must assent rather than give consent.|
> |167092|General appearance exam findings|Question|Coded|\N|
> |167092|Physical appearance exam findings|Question|Coded|\N|
> |167091|Clothed normally|Finding|N/A|\N|
> |167091|Wearing appropriate clothing|Finding|N/A|\N|
> |167091|Appropriate clothing for situation|Finding|N/A|\N|
> |167090|Appropriate weight|Finding|N/A|\N|
> |167090|Normal weight|Finding|N/A|\N|
> |167089|Inappropriately dressed|Finding|N/A|\N|
> |167089| Inappropriate clothing for situation|Finding|N/A|\N|
> |167088|Unkempt appearance|Finding|N/A|\N|
> |167088|Untidy|Finding|N/A|\N|
> |167087|Child behavior problem|Diagnosis|N/A|\N|
> |167087|Child behaviour problem|Diagnosis|N/A|\N|
> |167086|Adult behavior problem|Diagnosis|N/A|\N|
> |167086|Adult behaviour problem|Diagnosis|N/A|\N|
> |167085|Victim of sexual violence|Finding|N/A|\N|
> |167085|Survivor of sexual violence|Finding|N/A|\N|
> |167084|Orientation status|Question|Coded|\N|
> |167083|Oriented to time|Finding|N/A|\N|
> |167082|Oriented to place|Finding|N/A|\N|
> |167081|Oriented to person|Finding|N/A|\N|
> |167080|Feeling constantly worried|Finding|N/A|\N|
> |167079|Follow-up required status|Question|Coded|\N|
> |167079|Follow-up need status|Question|Coded|\N|
> |167078|Neurocognitive problem|Diagnosis|N/A|\N|
> |167078|Neurocognitive disorder|Diagnosis|N/A|\N|
> |167077|AP|Pharmacologic Drug Class|N/A|\N|
> |167077|Antipsychotics|Pharmacologic Drug Class|N/A|\N|
> |167077|Anti-psychotics|Pharmacologic Drug Class|N/A|\N|
> |167076|AD|Pharmacologic Drug Class|N/A|\N|
> |167076|Antidepressants|Pharmacologic Drug Class|N/A|\N|
> |167075|AX|Pharmacologic Drug Class|N/A|\N|
> |167075|Anxiolytics|Pharmacologic Drug Class|N/A|\N|
> |167074|Thoughts that you would be better off dead or of hurting yourself in some way|Question|Coded|\N|
> |167073|Moving or speaking so slowly that other people could have noticed or being so fidgety or restless that you have been moving around lot more than usual|Question|Coded|\N|
> |167072|Trouble concentrating on things such as reading the newspaper or watching television|Question|Coded|\N|
> |167071|Feeling bad about yourself or that you're a failure or have let yourself or your family down|Question|Coded|\N|
> |167070|Poor appetite or overeating over past two weeks|Question|Coded|\N|
> |167069|Feeling tired or having little energy over past two weeks|Question|Coded|\N|
> |167068|Trouble falling or staying asleep, or sleeping too much over past two weeks|Question|Coded|\N|
> |167067|Feeling afraid as if something awful might happen over past two weeks|Question|Coded|\N|
> |167066|Becoming easily annoyed or irritable over past two weeks|Question|Coded|\N|
> |167065|Being so restless that it's hard to sit still over past two weeks|Question|Coded|\N|
> |167064|Trouble relaxing over past two weeks|Question|Coded|\N|
> |167063|Psychiatry IPD|Misc|N/A|\N|
> |167063|Psychiatric inpatient department|Misc|N/A|\N|
> |167063|Inpatient psychiatry department|Misc|N/A|\N|
> |167062|Social worker|Misc|N/A|\N|
> |167061|Psychiatrist|Misc|N/A|\N|
> |167060|In transit/On the move|Finding|N/A|\N|
> |167059|Lives at relatives/friends' place|Finding|N/A|\N|
> |167058|Minor not living with family/guardian|Finding|N/A|\N|
> |167057|Minor living with family/guardian|Finding|N/A|\N|
> |167056|Hopelessness|Finding|N/A|\N|
> |167056|Feeling hopeless|Finding|N/A|\N|
> |167055|Sufficient breast milk production|Finding|N/A|\N|
> |167055|Adequate breast milk production|Finding|N/A|\N|
> |167054|Normal lochia odor|Finding|N/A|\N|
> |167053|Lochia odor|Question|Coded|\N|
> |167052|Involuting fundal height (cm below umbilicus)|Question|Numeric|\N|
> |167052|Uterus level from umbilicus during postpartum involution (cm)|Question|Numeric|\N|
> |167051|OPD mobile|Misc|N/A|\N|
> |167051|Mobile clinic|Misc|N/A|\N|
> |167050|IPD|Misc|N/A|\N|
> |167050|Hospital in-patient department|Misc|N/A|\N|
> |167050|Inpatient department|Misc|N/A|\N|
> |167049|Stable housing|Finding|N/A|\N|
> |167049|Stable accommodation|Finding|N/A|\N|
> |167048|Unstable housing|Finding|N/A|\N|
> |167048|Unstable accommodation|Finding|N/A|\N|
> |167047|Single parent family|Misc|N/A|\N|
> |---|---|---|---|---|
> |167046|No known exposure to tobacco smoke|Finding|N/A|\N|
> |167045|Secondhand tobacco exposure at work|Finding|N/A|\N|
> |167045|Exposed to tobacco smoke at work|Finding|N/A|\N|
> |167045|Second hand tobacco exposure at work|Finding|N/A|\N|
> |167044|Secondhand tobacco exposure at home|Finding|N/A|\N|
> |167044|Second hand tobacco exposure at home|Finding|N/A|\N|
> |167044|Exposed to tobacco smoke at home|Finding|N/A|\N|
> |167043|Restarted sexual intercourse|Question|Coded|\N|
> |167043|Resumed sexual intercourse|Question|Coded|\N|
> |167042|Quantity of lochia (qualitative)|Question|Coded|\N|
> |167041|Pfizer-BioNtech COVID-19 vaccine (infant)|Drug|N/A|For infants 2-5 y.o.|
> |167040|Pfizer-BioNtech COVID-19 vaccine (child)|Drug|N/A|For children 5-11 y.o.|
> |167039|Comirnaty|Drug|N/A|For adolescents 12-16 y.o.|
> |167039|Pfizer-BioNtech COVID-19 vaccine (adolescent)|Drug|N/A|For adolescents 12-16 y.o.|
> |167038|Involution of uterus|Question|Coded|\N|
> |167037|Non-tender uterus|Finding|N/A|\N|
> |167037|Uterus non-tender|Finding|N/A|\N|
> |167036|Tender uterus|Finding|N/A|\N|
> |167035|Findings on palpation of uterus|Question|Coded|\N|
> |167034|Polyvalent crotalidae antivenom|Drug|N/A|\N|
> |167034|Crotalic antivenom|Drug|N/A|\N|
> |167034|Crotalic antivenin|Drug|N/A|\N|
> |167033|Lung surfactant|Drug|N/A|\N|
> |167033|Pulmonary surfactant|Drug|N/A|\N|
> |167032|Loxosceles antivenom|Drug|N/A|\N|
> |167032|Loxoscelism antivenin|Drug|N/A|\N|
> |167032|Recluse spider antivenin|Drug|N/A|\N|
> |167031|Lachesis antivenom|Drug|N/A|\N|
> |167031|Lachesic antivenom|Drug|N/A|\N|
> |167031|Lachesic antivenin|Drug|N/A|\N|
> |167030|Bothropic antivenin|Drug|N/A|\N|
> |167030|Bothrops antivenin|Drug|N/A|\N|
> |167030|Bothropic antivenom|Drug|N/A|\N|
> |167029|isolanid|Drug|N/A|\N|
> |167029|Lanatoside C|Drug|N/A|\N|
> |167028|Erbitux|Drug|N/A|\N|
> |167028|Cetuximab|Drug|N/A|\N|
> |167027|Benznidazole|Drug|N/A|\N|
> |167027|Rochagan|Drug|N/A|\N|
> |167027|Radanil|Drug|N/A|\N|
> |167026|AZD7442|Drug|N/A|\N|
> |167026|Evusheld|Drug|N/A|\N|
> |167026|Cilgavimab / Tixagevimab|Drug|N/A|\N|
> |167025|replace|Drug|N/A|\N|
> |167024|PS|Misc|N/A|A partially-recognized state in the United Nations situated in the Middle East|
> |167024|Palestine|Misc|N/A|A partially-recognized state in the United Nations situated in the Middle East|
> ```
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for May 21, 2022!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for The WHO ANC DTK, MSF, PIH and COVID-19 (including new concepts for more vaccines). Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release. |concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|167286|Displaced person status|Finding|N/A|\N|
|167286|Displaced due to violent conflict|Finding|N/A|\N|
|167285|Non-violent conflict-related medical condition|Finding|N/A|\N|
|167284|Violent conflict-related medical condition|Finding|N/A|\N|
|167283|Repetitive game play|Finding|N/A|\N|
|167282|Illicit substance use|Finding|N/A|\N|
|167282|Illicit drug use|Finding|N/A|\N|
|167281|Long-acting injectable antipsychotics|Pharmacologic Drug Class|N/A|\N|
|167280|Permission to contact|Question|Coded|\N|
|167280|Authorization to contact|Question|Coded|\N|
|167279|Cause of stress (non-coded)|Question|Text|\N|
|167279|Stressor (text)|Question|Text|\N|
|167278|Stressors|Question|Coded|\N|
|167278|Cause of stress|Question|Coded|\N|
|167277|Therapeutic approach|Question|Text|\N|
|167276|Treatment objectives|Question|Text|\N|
|167276|Therapy objectives|Question|Text|\N|
|167275|Follow-up not required|Finding|N/A|\N|
|167275|Follow-up not needed|Finding|N/A|\N|
|167274|Needs follow-up|Finding|N/A|\N|
|167274|Follow-up required|Finding|N/A|\N|
|167273|Neurocognitive symptoms|Question|Coded|\N|
|167272|Psychosomatic symptoms|Question|Coded|\N|
|167271|Psychotic symptoms|Question|Coded|\N|
|167271|Psychosis symptoms|Question|Coded|\N|
|167270|Child behavioral symptoms|Question|Coded|\N|
|167269|Adult behavioral symptoms|Question|Coded|\N|
|167268|Trauma-related symptoms|Question|Coded|\N|
|167267|Anxiety symptoms|Question|Coded|\N|
|167266|Procedure not performed detail|ConvSet|N/A|\N|
|167265|Procedure/lab name|Question|Coded|Name of procedure or lab not performed or recorded for other reasons than being performed.|
|167264|Intramuscular administration of Minhai Biotechnology KCONVAC COVID-19 vaccine|Procedure|N/A|\N|
|167263|Minhai Biotechnology KCONVAC COVID-19 vaccine|Drug|N/A|\N|
|167262|Reason procedure not performed|Question|Coded|\N|
|167261|Intramuscular administration of Medigen COVID-19 vaccine|Procedure|N/A|\N|
|167260|Medigen COVID-19 vaccine|Drug|N/A|\N|
|167260|MVC-COV1901|Drug|N/A|\N|
|167259|Intramuscular administration of Biological E Limited Corbevax COVID-19 vaccine|Procedure|N/A|\N|
|167258|Biological E Limited Corbevax COVID-19 vaccine|Drug|N/A|Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. REF: https://en.wikipedia.org/wiki/Corbevax|
|167257|Intramuscular administration of Anhui Zhifei Longcom Zifivax COVID-19 vaccine|Procedure|N/A|\N|
|167256|ZF-UZ-VAC-2001|Drug|N/A|Anhui Zhifei Longcom and Institute of Microbiology at the Chinese Academy of Sciences COVID-19 Vaccine|
|167256|Anhui Zhifei Longcom Zifivax COVID-19 vaccine|Drug|N/A|Anhui Zhifei Longcom and Institute of Microbiology at the Chinese Academy of Sciences COVID-19 Vaccine|
|167255|Violence type experienced|Question|Coded|\N|
|167254|Private/safe space unavailable|Finding|N/A|Reason that evaluation not done or care not delivered|
|167253|Trained provider unavailable|Finding|N/A|Reason for evaluation not done or care not delivered|
|167252|Female genital pain|Finding|N/A|\N|
|167251|Pelvic lymphadenopathy|Diagnosis|N/A|\N|
|167251|Pelvic adenopathy|Diagnosis|N/A|\N|
|167250|More than 1 can of caffeinated soda or energy drink|Misc|N/A|\N|
|167249|More than 12 bars (50 g) of chocolate|Misc|N/A|\N|
|167248|More than 4 cups (400 ml) of regular tea|Misc|N/A|\N|
|167247|Provided infant formula|Question|Coded|\N|
|167246|History of previous forceps delivery|Finding|N/A|\N|
|167245|Alcohol use during pregnancy|Finding|N/A|\N|
|167245|Alcohol consumption during pregnancy|Finding|N/A|\N|
|167244|Victim of violence|Finding|N/A|\N|
|167244|Victim of physical violence|Finding|N/A|\N|
|167243|Victim of intimate partner abuse|Finding|Coded|\N|
|167243|Victim of intimate partner violence|Finding|Coded|\N|
|167242|Uterine contractions|Finding|N/A|Presence or complaints of uterine contractions, unspecified as to when in pregnancy.|
|167241|Lives with extended family|Finding|N/A|\N|
|167240|Lives with friends|Finding|N/A|\N|
|167239|Lives with siblings|Finding|N/A|\N|
|167238|Lives with parents|Finding|N/A|\N|
|167237|Increased skin temperature of breast|Finding|N/A|\N|
|167236|Peripheral cyanosis|Finding|N/A|\N|
|167235|Equipment malfunction|Finding|N/A|\N|
|167235|Device broken|Finding|N/A|\N|
|167235|Breast discharge|Finding|N/A|\N|
|167234|Equipment not available|Misc|N/A|\N|
|167234|Breast flushing|Misc|N/A|\N|
|167233|Unable to obtain blood pressure|Finding|Coded|\N|
|167232|Hot temperature|Finding|N/A|\N|
|167232|Hot sensation|Finding|N/A|\N|
|167231|Cold sensation|Finding|N/A|\N|
|167231|Cold temperature|Finding|N/A|\N|
|167230|Pump|Units of Measure|N/A|\N|
|167230|Pump (unit of administration)|Units of Measure|N/A|\N|
|167229|Need for specific test|Question|Coded|\N|
|167229|Need for specific laboratory test|Question|Coded|\N|
|167228|Lab referral tracking|ConvSet|N/A|\N|
|167227|Infection of perineal wound|Diagnosis|N/A|\N|
|167227|Perineum wound infection|Diagnosis|N/A|\N|
|167226|Echocardiogram findings|ConvSet|N/A|\N|
|167225|Medication education performed|Question|Coded|\N|
|167225|Medication training complete|Question|Coded|\N|
|167224|Living situation (text)|Question|Text|Living conditions are also available as coded concept|
|167223|Family educated about patient's illness|Question|Coded|\N|
|167222|History of homicidality|Question|Coded|\N|
|167222|History of homicidal ideation|Question|Coded|\N|
|167221|Have you ever felt you needed a drink first thing in the morning (eye-opener) to steady your nerves or to get rid of a hangover?|Question|Coded|\N|
|167221|Need for alcohol use first thing in the morning|Question|Coded|\N|
|167220|Have you ever felt guilty about drinking?|Question|Coded|\N|
|167220|Guilt about alcohol use|Question|Coded|\N|
|167219|Annoyed when criticized for alcohol use|Question|Coded|\N|
|167219|Have people annoyed you by criticizing your drinking? |Question|Coded|\N|
|167218|Have you ever felt you needed to cut down on your drinking?|Question|Coded|\N|
|167218|Felt need to cut down on alcohol use|Question|Coded|\N|
|167217|Score for CAGE questionnaire for detection of alcoholism|Question|Numeric|\N|
|167216|Performance of CAGE questionnaire for detection of alcoholism|Procedure|N/A|\N|
|167215|CAGE alcohol questionnaire questions|ConvSet|N/A|\N|
|167214|Relationship and involvement with children (text)|Question|Text|\N|
|167213|Common Elements Treatment Approach (CETA) completed|Question|Coded|\N|
|167212|Renal epithelial cells presence in urine sediment by light microscopy|Test|Coded|\N|
|167211|Epithelial cells presence in urine sediment by light microscopy|Test|Coded|\N|
|167210|Erythrocytes in urine sediment by light microscopy (count/HPF)|Test|Numeric|\N|
|167210|RBC in urine sediment by light microscopy per high power field|Test|Numeric|\N|
|167209|WBC in urine sediment by light microscopy per high power field|Test|Numeric|\N|
|167209|Leukocytes in urine sediment by light microscopy (count/HPF)|Test|Numeric|\N|
|167208|Cryptococcus detection in cerebrospinal fluid (CSF) by India ink preparation|Test|Coded|\N|
|167207|Cryptococcus Neoformans (india ink)|Test|Coded|\N|
|167207|Cryptococcus detection by India ink preparation|Test|Coded|\N|
|167206|Biktarvy|Drug|N/A|\N|
|167206|Bictegravir / emtricitabine / tenofovir alafenamide|Drug|N/A|\N|
|167205|Bictegravir|Drug|N/A|\N|
|167204|Veru-111|Drug|N/A|Antiviral used for COVID-19|
|167204|Sabizabulin|Drug|N/A|Antiviral used for COVID-19|
|167203|Ability to concentrate (qualitative)|Question|Coded|\N|
|167203|Level of concentration|Question|Coded|\N|
|167202|Memory status|Question|Coded|\N|
|167202|Memory performance|Question|Coded|\N|
|167201|Type of speech|Question|Coded|\N|
|167200|Impaired speech|Finding|N/A|\N|
|167199|Muted speech|Finding|N/A|\N|
|167198|Pressured speech|Finding|N/A|\N|
|167197|Fast speech|Finding|N/A|\N|
|167196|Soft speech|Finding|N/A|\N|
|167195|Loud speech|Finding|N/A|\N|
|167194|Spontaneous speech|Finding|N/A|\N|
|167193|Attitude toward interview|Question|Coded|\N|
|167192|Seductive behaviour|Finding|N/A|\N|
|167192|Seductive|Finding|N/A|\N|
|167192|Seductive behavior|Finding|N/A|\N|
|167191|Manipulative|Finding|N/A|\N|
|167191|Manipulative behavior|Finding|N/A|\N|
|167191|Manipulative behaviour|Finding|N/A|\N|
|167190|Defensive|Finding|N/A|\N|
|167190|Defensiveness|Finding|N/A|\N|
|167190|Defensive behaviour|Finding|N/A|\N|
|167190|Defensive behavior|Finding|N/A|\N|
|167189|Hostile|Finding|N/A|\N|
|167189|Hostile behavior|Finding|N/A|\N|
|167188|Cooperative|Finding|N/A|\N|
|167187|Gamma hydroxybutyrate (GHB) use|Finding|N/A|\N|
|167186|Hallucinogen use|Finding|N/A|\N|
|167185|Benzodiazepine misuse|Finding|N/A|\N|
|167184|Ayahuasca use|Finding|N/A|Psychedelic plant use|
|167183|Urine protein, 24 hour specimen (g)|Test|Numeric|\N|
|167182|Total lipids measurement (mg/dl)|Test|Numeric|\N|
|167181|Hallucination type|Question|Coded|\N|
|167181|Type of hallucinations|Question|Coded|\N|
|167180|Religious delusion|Finding|N/A|\N|
|167179|Delusion type|Question|Coded|\N|
|167179|Type of delusional disorder|Question|Coded|\N|
|167178|PPBS panel|LabSet|N/A|\N|
|167178|Post-prandial blood glucose panel|LabSet|N/A|\N|
|167177|Post-prandial blood glucose measurement (mg/dL) 2 hours after meal|Test|Numeric|\N|
|167177|PPBS 2 h|Test|Numeric|\N|
|167176|PPBS 1.5 h|Test|Numeric|\N|
|167176|Post-prandial blood glucose measurement (mg/dL) 1.5 hour after meal|Test|Numeric|\N|
|167175|Post-prandial blood glucose measurement (mg/dL) 1 hour after meal|Test|Numeric|\N|
|167174|PPBS 30 m|Test|Numeric|\N|
|167174|Post-prandial blood glucose measurement (mg/dL) 30 minutes after meal|Test|Numeric|\N|
|167174|Post-prandial blood glucose measurement (mg/dL) 1/2 hour after meal|Test|Numeric|\N|
|167173|Glucose, serum 1.5 hrs post 75g oral glucose (mg/dL)|Test|Numeric|\N|
|167173|GTT 1.5 hours test|Test|Numeric|\N|
|167172|Age of sexual partner (years)|Question|Numeric|\N|
|167171|Consent granted for sex|Question|Coded|\N|
|167171|Consent given for sex|Question|Coded|\N|
|167170|Datetime specimen sent to lab|Finding|Datetime|\N|
|167169|Age of oldest child (years)|Test|Numeric|\N|
|167169|Age of eldest child (years)|Test|Numeric|\N|
|167168|One sexual partner|Finding|Coded|\N|
|167168|Monogamous|Finding|Coded|\N|
|167167|Victim of neglect|Finding|N/A|\N|
|167166|Immunohistochemical stain|Test|N/A|\N|
|167166|Immune stain study|Test|N/A|\N|
|167166|Immunohistochemistry test|Test|N/A|\N|
|167165|History of exposure to domestic violence as a child|Diagnosis|Coded|\N|
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for August 14, 2022!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5.
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for The WHO ANC DTK, PIH, COVID-19, and several important concepts for documenting Monkeypox (disease and exposure) and vaccination. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was updated for this release, but will be distributed separately
concept_id | name | Class | Datatype | description |
---|---|---|---|---|
167440 | Exposure to suspected case of monkeypox | Finding | N/A | \N |
— | — | — | — | — |
167439 | Suspected monkeypox | Diagnosis | N/A | \N |
167438 | Administration of ACAM 2000 smallpox vaccine for monkeypox | Procedure | N/A | \N |
167438 | Administration of ACAM 2000 smallpox vaccine | Procedure | N/A | \N |
167437 | At increased risk of exposure to monkeypox virus | Finding | N/A | \N |
167436 | Close exposure to monkeypox virus | Finding | N/A | \N |
167435 | Administration of Jynneos smallpox and monkeypox vaccine | Procedure | N/A | \N |
167434 | Monkeypox confirmed using clinical diagnostic criteria | Diagnosis | N/A | \N |
167433 | Monkeypox excluded by laboratory test | Finding | N/A | \N |
167432 | Monkeypox excluded using clinical diagnostic criteria | Finding | N/A | \N |
167431 | Laboratory confirmed diagnosis of monkeypox | Diagnosis | N/A | \N |
167430 | Worse stage of retinopathy of prematurity (ROP) | Question | Coded | \N |
167429 | Perinatal intraventricular haemorrhage grade | Question | Coded | \N |
167429 | Perinatal intraventricular hemorrhage grade | Question | Coded | \N |
167428 | Perinatal intraventricular haemorrhage, grade 4 | Diagnosis | N/A | \N |
167428 | Perinatal intraventricular hemorrhage, grade IV | Diagnosis | N/A | \N |
167427 | Anticonvulsant therapy | Procedure | N/A | \N |
167426 | Interventions received in newborn unit | ConvSet | N/A | \N |
167425 | Therapeutic hypothermia | Procedure | N/A | \N |
167424 | Cranial ultrasound | Test | N/A | \N |
167423 | Neonatal exchange transfusion | Procedure | N/A | \N |
167422 | Light therapy | Procedure | N/A | \N |
167422 | Phototherapy | Procedure | N/A | \N |
167421 | Screening for retinopathy of prematurity | Procedure | N/A | \N |
167421 | ROP screen | Procedure | N/A | \N |
167420 | Administration of methylxanthine for neonatal apnea | Procedure | N/A | \N |
167419 | Pulmonary surfactant replacement | Procedure | N/A | \N |
167419 | Pulmonary surfactant therapy | Procedure | N/A | \N |
167418 | Administration of delayed kangaroo mother care | Procedure | N/A | \N |
167417 | Administration of epinephrine for resuscitation | Procedure | N/A | \N |
167416 | Delivery room interventions performed | Test | N/A | \N |
167415 | CPR | Procedure | Coded | \N |
167415 | Cardiopulmonary resuscitation (CPR) | Procedure | Coded | \N |
167414 | Delivery room interventions | Question | Coded | \N |
167413 | Date of previous admission | Question | Datetime | \N |
167413 | Date of prior admission | Question | Datetime | \N |
167412 | History of hospitalization for severe acute respiratory syndrome coronavirus 2 disease (SARS-COV-2) | Finding | Coded | \N |
167412 | History of hospitalization for COVID-19 | Finding | Coded | \N |
167411 | Triage | Misc | N/A | \N |
167411 | Triage service | Misc | N/A | \N |
167410 | Clinical consultation | Misc | N/A | \N |
167410 | Clinician-provided service | Misc | N/A | \N |
167409 | Service completed | Misc | N/A | \N |
167409 | Finished service | Misc | N/A | \N |
167408 | In service | Misc | N/A | Currently being cared for by service |
167407 | Waiting | Misc | N/A | \N |
167406 | Patient care administration status | Question | Coded | \N |
167405 | Presence of gram-positive bacilli in gram stain | Test | Coded | \N |
167404 | Arrangement of gram-positive cocci on gram stain | Test | Coded | \N |
167403 | Presence of gram-positive cocci on gram stain | Test | Coded | \N |
167402 | Finding of gram-positive cocci in chains | Finding | N/A | \N |
167401 | Finding of gram-positive cocci in clusters | Finding | N/A | \N |
167400 | Finding of gram-positive cocci in pairs | Finding | N/A | \N |
167399 | Arrangement of bacteria in specimen | Test | Coded | \N |
167398 | Yeast presence in specimen by gram stain | Test | Coded | \N |
167397 | Source of vaccination history information | Question | Coded | \N |
167397 | Source of immunization history information | Question | Coded | \N |
167396 | Stepdown unit | Misc | N/A | \N |
167396 | High dependency unit (HDU) | Misc | N/A | \N |
167395 | Admitted to location | Question | Coded | \N |
167395 | Admission to department location | Question | Coded | \N |
167394 | History of HIV-related opportunistic infections | Question | Coded | A field to capture history of HIV-related opportunistic infections experienced by patient. |
167393 | Isoniazid + Rifapentine | Misc | N/A | Drug regimen containing Isoniazid and Rifapentine |
167393 | Isoniazid / Rifapentine regimen | Misc | N/A | Drug regimen containing Isoniazid and Rifapentine |
167392 | Nutritional status | Question | Coded | \N |
167391 | Routine viral load | Procedure | N/A | \N |
167390 | Baseline viral load | Procedure | N/A | \N |
167389 | Recency assay | Procedure | N/A | Viral load testing is strongly recommended among those who test recent on TRI as part of recent infection testing algorithm (RITA). |
167388 | Confirmation of treatment failure | Procedure | N/A | \N |
167387 | Treatment failure | Finding | N/A | \N |
167386 | Early-onset neonatal sepsis | Finding | N/A | \N |
167385 | Sample rejected | Finding | N/A | \N |
167384 | Stimulation of newborn | Procedure | N/A | \N |
167384 | Neonatal stimulation | Procedure | N/A | \N |
167383 | Bag valve mask ventilation | Procedure | N/A | \N |
167383 | BVM | Procedure | N/A | \N |
167382 | Airway suctioning | Procedure | N/A | \N |
167381 | Patient meets trial/protocol criteria | Question | Coded | \N |
167380 | Treatment(s) dispensed or prescribed this encounter | Question | Coded | \N |
167379 | PLLV | Finding | N/A | A detectable viral load (above the LDL value) but < 1,000 copies/ml on two or more consecutive measures |
167379 | Persistent low-level viremia | Finding | N/A | A detectable viral load (above the LDL value) but < 1,000 copies/ml on two or more consecutive measures |
167378 | Low-level viremia | Finding | N/A | A detectable viral load (above the LDL value) but < 1,000 copies/ml |
167378 | LLV | Finding | N/A | A detectable viral load (above the LDL value) but < 1,000 copies/ml |
167377 | Studded epithelial cells, presence in body fluid | Test | Coded | \N |
167376 | Epithelial cells, presence in body fluid | Test | Coded | \N |
167375 | Urine drug screen positive in past 30 days | Finding | N/A | \N |
167374 | Religious faith healer | Misc | N/A | \N |
167373 | Duration of transfer/referral of care | Question | Coded | \N |
167372 | Temporary transfer of care | Procedure | N/A | \N |
167371 | Permanent transfer of care | Procedure | N/A | \N |
167370 | Current buprenorphine dose (mg) | Question | Numeric | \N |
167369 | Current dose of methadone (mg) | Question | Numeric | \N |
167368 | Type of memory loss | Question | Coded | \N |
167367 | Hemostatic hysterectomy postpartum | Procedure | N/A | \N |
167367 | Hysterectomy for postpartum hemorrhage | Procedure | N/A | \N |
167367 | Hysterectomy for postpartum haemorrhage | Procedure | N/A | \N |
167366 | Partial hysterectomy | Procedure | N/A | \N |
167366 | Subtotal hysterectomy | Procedure | N/A | \N |
167365 | Vibrio cholerae in stool by light microscopy | Test | Coded | \N |
167364 | Giardia lamblia in stool by light microscopy | Test | Coded | \N |
167363 | Entamoeba histolytica in stool by light microscopy | Test | Coded | \N |
167362 | Trichomonas intestinalis in stool by light microscopy | Test | Coded | \N |
167361 | Impairment of immediate recall | Finding | N/A | \N |
167361 | Impairment of registration (recall) | Finding | N/A | \N |
167360 | Dientamoeba fragilis in stool by iight microscopy | Test | Coded | \N |
167359 | Chilomastix mesnili in stool by light microscopy | Test | Coded | \N |
167358 | Entamoeba coli in stool by light microscopy | Test | Coded | \N |
167357 | Balantidium coli in stool by light microscopy | Test | Coded | \N |
167356 | Enterobius vermicularis in stool by light microscopy | Test | Coded | \N |
167355 | Strongyloide stercoralis in stool by light microscopy | Test | Coded | \N |
167354 | Beef tapeworm in stool by light microscopy | Test | Coded | \N |
167354 | Taenia saginata in stool by light microscopy | Test | Coded | \N |
167353 | Pork tapeworm in stool by light microscopy | Test | Coded | \N |
167353 | Taenia solium in stool by light microscopy | Test | Coded | \N |
167352 | Endolimax nana in stool by light microscopy | Test | Coded | \N |
167351 | Hymenolepis nana in stool by light microscopy | Test | Coded | \N |
167350 | Trichuris trichiura in stool by light microscopy | Test | Coded | \N |
167349 | Ancylostoma duodenale in stool by light microscopy | Test | Coded | \N |
167348 | Ascaris lumbricoides in stool by light microscopy | Test | Coded | \N |
167347 | Trichomonas intestinalis | Organism | N/A | |
167346 | Dientamoeba fragilis | Organism | N/A | \N |
167345 | Chilomastix mesnili | Organism | N/A | \N |
167344 | Entamoeba coli | Organism | N/A | \N |
167343 | Balantidium coli | Organism | N/A | \N |
167342 | Pinworm | Organism | N/A | \N |
167342 | Threadworm | Organism | N/A | \N |
167342 | Enterobius vermicularis | Organism | N/A | \N |
— | — | — | — | — |
167341 | Strongyloide stercoralis | Organism | N/A | \N |
167340 | Beef tapeworm | Organism | N/A | \N |
167340 | Taenia saginata | Organism | N/A | \N |
167339 | Pork tapeworm | Organism | N/A | \N |
167339 | Taenia solium | Organism | N/A | \N |
167338 | Endolimax nana | Organism | N/A | \N |
167337 | Hymenolepis nana | Organism | N/A | \N |
167336 | Trichuris trichiura | Organism | N/A | \N |
167335 | Ancylostoma duodenale | Organism | N/A | \N |
167334 | Stool examination for Ova and Parasite result | ConvSet | N/A | \N |
167333 | Quantity found on examination | Question | Coded | \N |
167332 | Many | Misc | N/A | \N |
167332 | Numerous | Misc | N/A | \N |
167331 | Ascaris lumbricoides | Organism | N/A | \N |
167330 | Stool for ova and parasites with concentration | Test | Coded | \N |
167329 | Ready to taper off opioid maintenance medication | Question | Coded | \N |
167328 | Remained on the same opioid maintenance dose for the past three months | Question | Coded | \N |
167328 | Remained on the same opioid maintenance dose for the last 3 months | Question | Coded | \N |
167327 | Stable income | Finding | Coded | \N |
167326 | Stopped engaging in criminal behavior | Question | Coded | \N |
167326 | Stopped engaging in criminal behaviour | Question | Coded | \N |
167325 | Comfortably resides in area away from drug-using sites | Question | Coded | \N |
167324 | Staying away from drug-using friends | Question | Coded | \N |
167323 | Able to cope with stressful situations without using drugs | Question | Coded | \N |
167322 | Employed | Finding | N/A | \N |
167321 | Patient memory ability | Question | Coded | \N |
167321 | Memory recall | Question | Coded | \N |
167320 | Logical thinking | Finding | N/A | \N |
167319 | Illogical thinking | Finding | N/A | \N |
167318 | Pressured thought | Finding | N/A | \N |
167318 | Pressure of thought | Finding | N/A | \N |
167317 | Elated | Finding | N/A | \N |
167316 | No involuntary movements | Finding | N/A | \N |
167315 | Uncooperative behavior | Finding | N/A | \N |
167315 | Uncooperative behaviour | Finding | N/A | \N |
167315 | Uncooperative | Finding | N/A | \N |
167314 | Withdrawal method of contraception | Finding | N/A | \N |
167313 | Fraud/Forgery | Finding | N/A | \N |
167312 | Robbery | Finding | N/A | \N |
167311 | Burglary/Larceny | Finding | N/A | \N |
167310 | Weapons offense | Finding | N/A | \N |
167309 | Drug possession | Finding | N/A | \N |
167308 | Drunk and disorderly conduct | Finding | N/A | \N |
167307 | History of violent behaviour | Finding | N/A | \N |
167307 | History of violent behavior | Finding | N/A | \N |
167306 | Education about possible consequences of non-compliance to Medically Assisted Therapy (MAT) agreements | Procedure | N/A | \N |
167305 | Education about dangers of continued use of substances while on Medically Assisted Therapy (MAT) | Procedure | N/A | \N |
167304 | BA.2.75 variant | Misc | N/A | \N |
167304 | Centaurus variant | Misc | N/A | \N |
167303 | Dependent drug detoxification therapy | Procedure | N/A | \N |
167302 | Population prevalence of hepatitis C | Question | Numeric | \N |
167301 | Population prevalence of hepatitis B | Question | Numeric | \N |
167300 | Population prevalence of syphilis in pregnant women | Question | Numeric | \N |
167299 | Population prevalence of HIV in pregnant women | Question | Numeric | \N |
167298 | Population prevalence of HIV in key populations | Question | Numeric | Population prevalence of HIV in key populations (men who have sex with men, people in prison or other closed settings, people who inject drugs, sex workers and transgender people) |
167297 | Population incidence of HIV (/100 person*years) | Question | Numeric | Population incidence of HIV in the absence of PrEP |
167296 | Population prevalence of soil-transmitted helminth infection | Question | Numeric | \N |
167295 | Population prevalence of tuberculosis (TB) | Question | Numeric | \N |
167294 | Population prevalence of anaemia | Question | Numeric | \N |
167294 | Population prevalence of anemia | Question | Numeric | \N |
167293 | Population prevalence of malnourishment | Question | Numeric | \N |
167293 | Population prevalence of undernourishment | Question | Numeric | \N |
167292 | BA.5 variant | Misc | N/A | \N |
167291 | BA.4 variant | Misc | N/A | \N |
167290 | BA.2.12.1 variant | Misc | N/A | \N |
167289 | BA.3 variant | Misc | N/A | \N |
167288 | BA.2 variant | Misc | N/A | \N |
167287 | Family medication required | Question | Coded | \N |
167287 | Family medication needed | Question | Coded | \N |
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for October 12, 2022! Sorry that I forgot to notify of the September release!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in version prior to 1.11
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes many new concepts for Oncology (drug ingredients) and a few new concepts for COVID. Please update your dictionaries.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was updated for this release, but will be distributed separately
concept_id name Class Datatype description
167619 Erismodegib Drug N/A
167619 Odomzo Drug N/A
167619 Sonidegib Drug N/A
167618 Provenge Drug N/A
167618 Sipuleucel-T Drug N/A
167617 Retsevmo Drug N/A
167617 Selpercatinib Drug N/A
167617 Retevmo Drug N/A
167616 Selinexor Drug N/A
167616 Xpovio Drug N/A
167615 Sacituzumab govitecan Drug N/A
167615 Trodelvy Drug N/A
167614 Jakavi Drug N/A
167614 Opzelura Drug N/A
167614 Jakafi Drug N/A
167614 Ruxolitinib Drug N/A
167613 Rubraca Drug N/A
167613 Rucaparib Drug N/A
167612 Romidepsin Drug N/A
167612 Istodax Drug N/A
167611 Rituxan Hycela Drug N/A
167611 Hyaluronidase / rituximab Drug N/A
167610 Ruxience Drug N/A
167610 Rituximab-pvvr Drug N/A
167609 Riabni Drug N/A
167609 Rituximab-arrx Drug N/A
167608 Truxima Drug N/A
167608 Rituximab-abbs Drug N/A
167607 Ripretinib Drug N/A
167607 Qinlock Drug N/A
167606 Ribociclib Drug N/A
167606 Kisqali Drug N/A
167606 Kryxana Drug N/A
167605 Myfembree Drug N/A
167605 Estradiol / norethindrone / relugolix Drug N/A
167604 Relugolix Drug N/A
167604 Relumina Drug N/A
167604 Orgovyx Drug N/A
167603 Regonix Drug N/A
167603 Regorafenib Drug N/A
167603 Renib Drug N/A
167603 Resihance Drug N/A
167603 Stivarga Drug N/A
167603 Nublexa Drug N/A
167602 Ravulizumab Drug N/A
167602 Ultomiris Drug N/A
167602 ravulizumab-cwvz Drug N/A
167601 Ramucirumab Drug N/A
167601 Cyramza Drug N/A
167600 Radium chloride RA-223 Drug N/A
167600 Alpharadin Drug N/A
167600 Xofigo Drug N/A
167599 Gavreto Drug N/A
167599 Pralsetinib Drug N/A
167598 Folotyn Drug N/A
167598 Pralatrexate Drug N/A
167597 Iclusig Drug N/A
167597 Ponatinib Drug N/A
167596 3-amino-thalidomide Drug N/A
167596 Pomalid Drug N/A
167596 Pomalidomide Drug N/A
167596 Ibipolid Drug N/A
167596 Imnovid Drug N/A
167596 Actimid Drug N/A
167596 Pomalyst Drug N/A
167595 Polatuzumab vedotin-piiq Drug N/A
167595 Polatuzumab vedotin Drug N/A
167595 Polivy Drug N/A
167594 Phesgo Drug N/A
167594 Hyaluronidase / pertuzumab / trastuzumab Drug N/A
167593 Perjeta Drug N/A
167593 Omnitarg Drug N/A
167593 Pertuzumab Drug N/A
167592 Turalio Drug N/A
167592 Pexidartinib Drug N/A
167591 Pemigatinib Drug N/A
167591 Pemazyre Drug N/A
167590 Pembrolizumab Drug N/A
167590 Keytruda Drug N/A
167590 Lambrolizumab Drug N/A
167589 Pazopanib Drug N/A
167589 Votrient Drug N/A
167589 Pazopater Drug N/A
167588 Panobinostat lactate anhydrous Drug N/A
167588 Farydak Drug N/A
167588 Faridak Drug N/A
167588 Panobinostat Drug N/A
167587 Panitumumab Drug N/A
167587 Vectibix Drug N/A
167586 Pacritinib Drug N/A
167586 Vonjo Drug N/A
167585 Osimert Drug N/A
167585 Osimertinib Drug N/A
167585 Tagrisso Drug N/A
167585 Tagrix Drug N/A
167584 Synribo Drug N/A
167584 Omapro Drug N/A
167584 Omacetaxine mepesuccinate Drug N/A
167583 Olaparix Drug N/A
167583 Olanib Drug N/A
167583 Lynparza Drug N/A
167583 Olaparib Drug N/A
167582 Afutuzumab Drug N/A
167582 Gazyva Drug N/A
167582 Obinutuzumab Drug N/A
167581 Nivolumab / relatlimab Drug N/A
167581 Opdualag Drug N/A
167580 Nivolumab Drug N/A
167580 Opdivo Drug N/A
167579 Zejula Drug N/A
167579 Niranib Drug N/A
167579 Niraparib Drug N/A
167578 Ofev Drug N/A
167578 Nintenib Drug N/A
167578 Idofnib Drug N/A
167578 Nifev Drug N/A
167578 Nintena Drug N/A
167578 Nintib Drug N/A
167578 Vargatef Drug N/A
167578 Nindanib Drug N/A
167578 Nintedanib Drug N/A
167578 Cyendiv Drug N/A
167577 Neratinib Drug N/A
167577 Nerlynx Drug N/A
167576 Ebola Sudan virus disease Diagnosis N/A
167576 Ebola infection, Sudan virus Diagnosis N/A
167575 Necitumumab Drug N/A
167575 Portrazza Drug N/A
167574 Danyelza Drug N/A
167574 Naxitamab-gqgk Drug N/A
167574 Naxitamab Drug N/A
167573 Moxetumomab pasudotox Drug N/A
167573 Lumoxiti Drug N/A
167573 Moxetumomab pasudotox-tdfk Drug N/A
167572 Mogamulizumab-kpkc Drug N/A
167572 Mogamulizumab Drug N/A
167572 Poteligeo Drug N/A
167571 Exkivity Drug N/A
167571 Mobocertinib Drug N/A
167570 Tauritmo Drug N/A
167570 Midostaurin Drug N/A
167570 Rydapt Drug N/A
167569 Mepolizumab Drug N/A
167569 Nucala Drug N/A
167568 Margetuximab Drug N/A
167568 Margenza Drug N/A
167568 Margetuximab-cmkb Drug N/A
167567 Pluvicto Drug N/A
167567 Lutetium Lu 177 vipivotide tetraxetan Drug N/A
167566 Lutathera Drug N/A
167566 Lutetium Lu 177 dotatate Drug N/A
167565 Zepzelca Drug N/A
167565 Lurbinectedin Drug N/A
167564 Lorlatinib Drug N/A
167564 Lorbrena Drug N/A
167563 Loncastuximab tesirine-lpyl Drug N/A
167563 Zynlonta Drug N/A
167563 Loncastuximab tesirine Drug N/A
167562 Lisocabtagene maraleucel Drug N/A
167562 Liso-cel Drug N/A
167562 Breyanzi Drug N/A
167561 Levoleucovorin Drug N/A
167561 Fusilev Drug N/A
167561 Khapzory Drug N/A
167560 Lenvatinib Drug N/A
167560 Lenvima Drug N/A
167559 Larotrectinib Drug N/A
167559 Vitrakvi Drug N/A
167558 Herlapsa Drug N/A
167558 Abnib Drug N/A
167558 Hertab Drug N/A
167558 Lapanix Drug N/A
167558 Combinib Drug N/A
167558 Lapatem Drug N/A
167558 Etibo Drug N/A
167558 Tykerb Drug N/A
167558 Herduo Drug N/A
167558 Lapatinib Drug N/A
167558 Tyverb Drug N/A
167557 Ixazomib Drug N/A
167557 Ninlaro Drug N/A
167556 Ivosidenib Drug N/A
167556 Tibsovo Drug N/A
167555 Isatuximab Drug N/A
167555 Sarclisa Drug N/A
167554 Interpretation of major crossmatch results Test Text
167553 Irinotecan liposomal Drug N/A
167553 Onivyde Drug N/A
167553 Irinotecan liposome Drug N/A
167552 Ipilimumab Drug N/A
167552 Yervoy Drug N/A
167551 Besponsa Drug N/A
167551 Inotuzumab ozogamicin Drug N/A
167550 Infigratinib Drug N/A
167550 Truseltiq Drug N/A
167549 Idecabtagene vicleucel Drug N/A
167549 Abecma Drug N/A
167548 Ibrutinib Drug N/A
167548 Lucibru Drug N/A
167548 Ibrutix Drug N/A
167548 Ibrunib Drug N/A
167548 Imbruvica Drug N/A
167547 Glasdegib Drug N/A
167547 Daurismo Drug N/A
167546 Gilteritinib Drug N/A
167546 Xospata Drug N/A
167545 Gemtuzumab ozogamicin Drug N/A
167545 Mylotarg Drug N/A
167544 Locametz Drug N/A
167544 Gallium ga-68 gozetotide Drug N/A
167543 Lytgobi Drug N/A
167543 Futibatinib Drug N/A
167542 Tavalisse Drug N/A
167542 Fostamatinib Drug N/A
167541 Fedratinib Drug N/A
167541 Inrebic Drug N/A
167540 Trastuzumab deruxtecan Drug N/A
167540 Enhertu Drug N/A
167539 Eltrom Drug N/A
167539 Eltrombopag Drug N/A
167539 Revolade Drug N/A
167539 Promacta Drug N/A
New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for November 4, 2022!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.
https://app.openconceptlab.org/#/orgs/CIEL/
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes new concepts for Oncology (drug ingredients) and new concepts for MSF, the new Kenya HDD/KenyaEMR including reasons for COVID vaccine rejection and new COVID-19 variants. The COVID-19 starter collection was also updated.
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.
concept_id name Class Datatype description
167715 Class of psychotropic medication initiated Question Coded
167714 Ligament of pelvic girdle Anatomy N/A
167714 Ligament of pelvis Anatomy N/A
167713 Sofosbuvir / Daclatasvir Drug N/A
167713 Daclatasvir / Sofosbuvir Drug N/A
167713 Sovodak Drug N/A
167712 Prior drug treatment program participation Question Coded
167711 > 1 yr Misc N/A
167711 Greater than one year Misc N/A
167711 > 1 yr Misc N/A
167710 < 1 yr Misc N/A
167710 Less than one year Misc N/A
167710 < 1 yr Misc N/A
167709 One year Misc N/A
167709 1 yr Misc N/A
167708 Positive COVID-19 protocol Question Coded
167708 Positive SARS-CoV-2 protocol Question Coded
167707 United Nations Relief and Works Agency for Palestine Refugees in the Near East Misc N/A
167707 UNRWA Misc N/A
167706 Médecins Sans Frontières West and Central Africa Misc N/A
167706 MSF WaCA Misc N/A
167705 Médecins Sans Frontières Paris Misc N/A
167705 MSF OCP Misc N/A
167704 MSF OCBA Misc N/A
167704 Médecins Sans Frontières Barcelona-Athens Misc N/A
167703 Médecins Sans Frontières Geneva Misc N/A
167703 Médecins Sans Frontières Geneva Misc N/A
167703 MSF OCG Misc N/A
167703 Médecins Sans Frontières Geneva Misc N/A
167702 Médecins Sans Frontières Brussels Misc N/A
167702 Médecins Sans Frontières Brussels Misc N/A
167702 Médecins Sans Frontières Brussels Misc N/A
167702 MSF OCB Misc N/A
167701 Delusion that vaccine is combined with contraceptive Finding N/A
167700 Delusion that vaccines will kill them Finding N/A
167699 Delusion that antiretrovirals can cure/prevent COVID-19 Finding N/A
167698 Delusion that vaccine replicates DNA Finding N/A
167698 Delusion that vaccine replicates one&#39;s DNA Finding N/A
167698 Delusion that vaccine replicates one's DNA Finding N/A
167698 Delusion that vaccine replicates one's DNA Finding N/A
167697 Concerned about safety in immunocompromised people Finding N/A For example, in PLHIV or HIV-infected people
167696 Individual therapy Procedure N/A
167696 Individual psychotherapy Procedure N/A
167695 Group therapy Procedure N/A
167695 Group psychotherapy Procedure N/A
167694 Session type Question Coded The type of therapy session attended
167693 Session attended ConvSet N/A
167692 Isoniazid / Rifapentine Drug N/A Fixed combination medication with INH and Rifapentine
167691 Detained by authorities Finding N/A
167690 Significant change in social role/position Finding N/A
167689 Witness to violence Finding N/A
167688 Sickness in family Finding N/A
167688 Relative/family member sick Finding N/A
167687 Loss of relative/family member Finding N/A Relative or family member has died, been detained, is missing, etc.
167686 Relational problem with family member Finding N/A
167685 Non-governmental organisation Misc N/A
167685 Non-governmental organization Misc N/A
167685 Non-governmental organization Misc N/A
167685 Nongovernmental organization Misc N/A
167685 NGO Misc N/A
167684 Sofobuvir / velpatasvir Drug N/A
167684 Sofosbuvir / velpatasvir Drug N/A
167684 Epclusa Drug N/A
167683 Aware of conditions that could lead to involuntary discharge from Medically Assisted Therapy (MAT) Question Coded
167682 History of complications related to injecting drug use Question Coded
167682 History of complications related to intravenous drug use Question Coded
167681 IVDU reason Question Coded
167681 Reason for using intravenous drugs Question Coded
167680 Theft/Property damage of clinic/instituation Finding N/A
167679 Diversion of buprenorphine Finding N/A
167679 Stealing buprenorphine Finding N/A
167678 Diversion of methadone Finding N/A
167678 Stealing methadone Finding N/A
167677 Wearing guns/weapons Finding N/A
167677 Weapons possession Finding N/A
167676 Delusion about being immune to disease Finding N/A
167675 Fear of drug class interaction with vaccine Question Coded
167674 Media-induced fear of vaccination Finding N/A
167674 Media-induced fear of immunization Finding N/A
167673 Insufficient vaccine testing/study Finding N/A
167673 Concerned about insufficient vaccine testing/study Finding N/A
167673 Insufficient vaccine testing/study Finding N/A
167672 Flashblood user Question Coded
167672 Flushblood user Question Coded
167671 Number of missed appointments Question Numeric
167670 Involuntary discharge from program Procedure N/A
167669 Reason for no show Question Coded
167669 Reason for defaulting Question Coded
167668 Date enrolled in substance abuse program Question Datetime
167667 Court system Misc N/A
167667 Criminal justice system Misc N/A
167666 Previous referral for Medically Assisted Therapy (MAT) services Question Coded
167665 Recommended for immediate enrollment for Medically Assisted Therapy (MAT) Question Coded
167664 Ceritinib Drug N/A
167664 Zykadia Drug N/A
167664 Lucicer Drug N/A
167664 Spexib Drug N/A
167664 Noxalk Drug N/A
167663 Libtayo Drug N/A
167663 Cemiplimab Drug N/A
167662 Carfilnat Drug N/A
167662 Carfilzomib Drug N/A
167662 Kyprolis Drug N/A
167661 Mannerisms Finding N/A
167660 Zirabev Drug N/A
167660 Bevacizumab-bvzr Drug N/A
167659 Mvasi Drug N/A
167659 Bevacizumab-awwb Drug N/A
167658 Bevacizumab-adcd Drug N/A
167658 Vegzelga Drug N/A
167657 Fasenra Drug N/A
167657 Benralizumab Drug N/A
167656 In good standing Misc N/A Program status where patient/enrollee is still enrolled and in good standing.
167655 Cost of vaccination Misc N/A Potential reason for not receiving care
167655 Cost of immunization Misc N/A Potential reason for not receiving care
167654 Delay time for results Misc N/A
167654 Waiting time for results Misc N/A
167653 Wait time for procedure Misc N/A
167653 Delay time for procedure Misc N/A
167653 Wait time Misc N/A
167653 Delay time Misc N/A
167652 Vaccine-related death Finding N/A
167652 Death due to immunization Finding N/A
167652 Death due to vaccination Finding N/A
167651 At risk for clots Finding N/A
167651 At risk of venous thromboembolism Finding N/A
167650 Type of fear regarding vaccination Question Coded
167650 Fears about vaccination Question Coded
167649 XBB variant Misc N/A SARS-CoV-2 (COVID-19) virus variant
167648 BQ.1.1 variant Misc N/A SARS-CoV-2 (COVID-19) virus variant
167647 Zaltrap Drug N/A
167647 Ziv-aflibercept Drug N/A
167646 Brukinsa Drug N/A
167646 Zanubrutinib Drug N/A
167645 Voxelotor Drug N/A
167645 Oxbryta Drug N/A
167644 Vorinostat Drug N/A
167644 Zolinza Drug N/A
167643 Erivedge Drug N/A
167643 Vismodegib Drug N/A
167642 Javlor Drug N/A
167642 Vinflunine Drug N/A
167641 Vincristine liposomal Drug N/A
167641 Vincristine liposome Drug N/A
167641 Marqibo Drug N/A
167640 Venclexta Drug N/A
167640 Venetoclax Drug N/A
167639 Vemurafenib Drug N/A
167639 Zelboraf Drug N/A
167638 Caprelsa Drug N/A
167638 Zactima Drug N/A
167638 Lucivand Drug N/A
167638 Vandetanib Drug N/A
167637 Ukoniq Drug N/A
167637 Umbralisib Drug N/A
167636 Tucatinib Drug N/A
167636 Irbinitinib Drug N/A
167636 Tukysa Drug N/A
167635 trastuzumab-oysk and hyaluronidase-oysk Drug N/A
167635 Herceptin hylecta Drug N/A
167635 Hyaluronidase / trastuzumab Drug N/A
167634 Trastuzumab-qyyp Drug N/A
167634 Trazimera Drug N/A
167633 Herzuma Drug N/A
167633 Trastuzumab-pkrb Drug N/A
167632 Ontruzant Drug N/A
167632 Trastuzumab-dttb Drug N/A
167631 Ogivri Drug N/A
167631 Trastuzumab-dkst Drug N/A
167630 Kanjinti Drug N/A
167630 Trastuzumab-anns Drug N/A
167629 Mekinist Drug N/A
167629 Trametinib Drug N/A
167629 Meqsel Drug N/A
167628 Trabectedin Drug N/A
167628 Yondelis Drug N/A
167627 Kymriah Drug N/A
167627 Tisagenlecleucel Drug N/A
167626 Tepmetko Drug N/A
167626 Tepotinib Drug N/A
167625 Telotristat ethyl Drug N/A
167625 Xermelo Drug N/A
167624 Tazemetostat Drug N/A
167624 Tazverik Drug N/A
167623 Talzenna Drug N/A
167623 Talazoparib Drug N/A
167622 Tagraxofusp Drug N/A
167622 Elzonris Drug N/A
167622 Tagraxofusp-erzs Drug N/A
167621 Tafasitamab-cxix Drug N/A
167621 Monjuvi Drug N/A
167621 Tafasitamab Drug N/A
167620 Sotorasib Drug N/A
167620 Lumakras Drug N/A
New version of CIEL dictionary added to dropbox AND soon to be updated on Open Concept Lab for December 21, 2022!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.
https://app.openconceptlab.org/#/orgs/CIEL/
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes new concepts for Oncology (drug ingredients) and new concepts for MSF, the new Kenya HDD/KenyaEMR, coded HIV ART regimens, and updated normal ranges for vitals for OMRS 3.0 .
It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.
The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.
|concept_id|name|Class|Datatype|description| |---|---|---|---|---| |167825|Severe pregnancy-induced hypertension|Diagnosis|N/A|| |167825|Severe gestational hypertension|Diagnosis|N/A|| |167824|Host|Misc|N/A|A person living within a host community which is hosting internally displaced persons (IDPs) in the homes of community members and/or in spontaneous or formal camps nearby.| |167823|Legal status|Question|Coded|| |167822|Occupational exposure to risk factor|Finding|N/A|| |167822|Occupational exposure|Finding|N/A|| |167821|Number of disease exacerbations|Question|Numeric|| |167820|Number of disease exacerbations construct|ConvSet|N/A|| |167819|Missed medication doses in past seven days|Question|Coded|| |167819|Missed medication doses in seven days|Question|Coded|| |167819|Missed medication doses in last week|Question|Coded|| |167819|Number of missed medication doses in seven days|Question|Coded|| |167819|Number of missed medication doses in last week|Question|Coded|| |167818|Last date of discharge from hospital|Question|Date|| |167818|Most recent date of discharge from hospital|Question|Date|| |167817|Hypoglycemic event since last visit|Question|Coded|Whether the patient has experienced a hypoglycemic event since the last visit.| |167817|Hypoglycaemia since last visit|Question|Coded|Whether the patient has experienced a hypoglycemic event since the last visit.| |167816|Previous mental health treatment|Question|Coded|What mental health care and services the patient had previously received.| |167816|History of mental health treatment|Question|Coded|What mental health care and services the patient had previously received.| |167815|Protective services|Misc|N/A|| |167815|Protection services|Misc|N/A|| |167814|Legal services|Misc|N/A|| |167813|SRH|Misc|N/A|| |167813|Sexual/reproductive health service|Misc|N/A|| |167812|Instructions|Procedure|Coded|| |167812|Recommendations to clinician/department|Procedure|Coded|| |167811|Vaginal cancer|Diagnosis|N/A|| |167811|Malignant neoplasm of vagina|Diagnosis|N/A|| |167810|HCV Ag|Test|Coded|| |167810|Hepatitis C viral antigen measurement|Test|Coded|| |167809|Patient education|Procedure|N/A|| |167808|24 weeks|Misc|N/A|Generic answer to a question.| |167808|Twenty-four weeks|Misc|N/A|Generic answer to a question.| |167807|Twelve weeks|Misc|N/A|Generic answer to a question| |167807|12 weeks|Misc|N/A|Generic answer to a question| |167806|Very much worse|Misc|N/A|Severe exacerbation of symptoms and loss of functioning| |167805|Much worse|Misc|N/A|Clinically significant increase in symptoms and diminished functioning| |167804|Minimally worse|Misc|N/A|Slightly worse but may not be clinically meaningful; may represent very little change in basic clinical status or functional capacity| |167803|Minimally improved|Finding|N/A|Slightly better with little or no clinically meaningful reduction of symptoms. Represents very little change in basic clinical status, level of care, or functional capacity| |167802|Much improved|Finding|N/A|Notably better with significant reduction of symptoms; increase in the level of functioning but some symptoms remain| |167801|Very much improved|Finding|N/A|Nearly all better; good level of functioning; minimal symptoms; represents a very substantial change| |167800|Clinical Global Impression Severity Set|ConvSet|N/A|| |167800|CGI-S set|ConvSet|N/A|| |167799|Extremely ill|Finding|N/A|Among the most extremely ill patients&mdash;pathology drastically interferes in many life functions; may be hospitalized| |167798|Severely ill|Finding|N/A|Disruptive pathology, behavior and function are frequently influenced by symptoms, may require assistance from others| |167797|Markedly ill|Finding|N/A|Intrusive symptoms that distinctly impair social/occupational function or cause intrusive levels of distress| |167796|Moderately ill|Finding|N/A|Overt symptoms causing noticeable, but modest, functional impairment or distress; symptom level may warrant medication| |167795|Mildly ill|Finding|N/A|Clearly established symptoms with minimal, if any, distress or difficulty in social and occupational function| |167794|Borderline ill|Finding|N/A|Subtle or suspected pathology| |167793|Sofosbuvir / Velpatasvir / Voxilaprevir|Drug|N/A|| |167793|Vosevi|Drug|N/A|| |167792|DRV/r+ABC+EFV+3TC child regimen|Misc|N/A|| |167792|Abacavir / Darunavir / Efavirenz / Lamivudine / Ritonavir child regimen|Misc|N/A|| |167792|6G - DRV/r+ABC+3TC+EFV child|Misc|N/A|| |167791|6F - DRV/r+DTG+ABC+3TC child|Misc|N/A|| |167791|Abacavir / Darunavir / Dolutegravir / Lamivudine / Ritonavir child regimen|Misc|N/A|| |167791|DRV/r+ABC+3TC+DTG child regimen|Misc|N/A|| |167790|Antiretroviral treatment started|Question|Coded|| |167790|ARV treatment started|Question|Coded|| |167790|ART started|Question|Coded|| |167789|Case confirmed bacteriologically|Question|Coded|| |167789|Diagnosis confirmed bacteriologically|Question|Coded|| |167788|Reason for visit (coded)|Question|Coded|| |167787|hepatitis C virus RNA viral load by probe and target amplification method (IU/ml)|Test|Numeric|| |167787|Hepatitis C virus RNA PCR quantitative (IU/ml)|Test|Numeric|| |167787|HCV RNA PCR quantitative (IU/ml)|Test|Numeric|| |167787|HCV PCR quant|Test|Numeric|| |167786|HCV PCR qualitative|Test|Coded|| |167786|Hepatitis C virus (HCV) nucleic acid detection by PCR in serum/plasma|Test|Coded|| |167785|HBV e Ag|Test|Coded|Presence of Hepatitis B viral e antigen in serum/plasma| |167785|Hepatitis B virus e antigen assay|Test|Coded|Presence of Hepatitis B viral e antigen in serum/plasma| |167784|Was procedure performed/carried out|Question|Coded|| |167783|Willing to participate in methadone maintenance treatment|Question|Coded|| |167782|6H - DRV/r+AZT+3TC+EFV child|Misc|N/A|| |167782|Darunavir / Efavirenz / Lamivudine / Ritonavir / Zidovudine child regimen|Misc|N/A|| |167782|3TC/AZT/EFV/DRV/r child regimen|Misc|N/A|| |167781|Darunavir / Efavirenz / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A|| |167781|3F - DRV/r+AZT+3TC+EFV adult|Misc|N/A|| |167781|3TC/AZT/EFV/DRV/r adult regimen|Misc|N/A|| |167780|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir child regimen|Misc|N/A|| |167780|3TC/DRV/DTG/RTV/TDF child regimen|Misc|N/A|| |167780|6D - DRVr+DTG+TDF+3TC child|Misc|N/A|| |167779|6C - DRVr+DTG+AZT+3TC child|Misc|N/A|| |167779|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Zidovudine child regimen|Misc|N/A|| |167778|3E - DRV/r+TDF+3TC+EFV adult|Misc|N/A|| |167778|Darunavir / Efavirenz / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A|| |167778|DRV/r+TDF+3TC+EFV adult regimen|Misc|N/A|| |167777|DRV/r+ABC+3TC+DTG adult regimen|Misc|N/A|| |167777|3C - DRV/r+ABC+3TC+DTG adult|Misc|N/A|| |167777|Abacavir / Darunavir / Dolutegravir / Lamivudine / Ritonavir adult regimen|Misc|N/A|| |167776|3B - DRVr+DTG+TDF/3TC adult|Misc|N/A|| |167776|3TC/DRV/DTG/RTV/TDF adult regimen|Misc|N/A|| |167776|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A|| |167775|3A - DRVr+DTG+AZT/3TC adult regimen|Misc|N/A|| |167775|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A|| |167774|3TC/ABC/RAL child regimen|Misc|N/A|| |167774|Abacavir / Lamivudine / Raltegravir child regimen|Misc|N/A|| |167774|5L - RAL+ABC+3TC child|Misc|N/A|| |167773|Lamivudine / Raltegravir / Zidovudine child regimen|Misc|N/A|| |167773|3TC/AZT/RAL child regimen|Misc|N/A|| |167773|5K - RAL+AZT+3TC child|Misc|N/A|| |167772|3TC/ABC/LPV/r adult regimen|Misc|N/A|| |167772|Abacavir / Lamivudine / Lopinavir / Ritonavir adult regimen|Misc|N/A|| |167772|2I - ABC+3TC+LPVr adult|Misc|N/A|| |167771|2H - TDF+3TC+ATVr adult|Misc|N/A|| |167771|Atazanavir / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A|| |167771|TDF/3TC/ATV/r adult regimen|Misc|N/A|| |167770|5I - TDF+3TC+LPVr child|Misc|N/A|| |167770|Lamivudine / Lopinavir / Ritonavir / Tenofovir child regimen|Misc|N/A|| |167770|3TC/LPV/r/TDF child regimen|Misc|N/A|| |167769|2G - TDF+3TC+LPVr adult|Misc|N/A|| |167769|Lamivudine / Lopinavir / Ritonavir / Tenofovir adult regimen|Misc|N/A|| |167769|3TC/LPV/r/TDF adult regimen|Misc|N/A|| |167768|2F - AZT+3TC+ATVr adult|Misc|N/A|| |167768|AZT-3TC-ATV/r adult regimen|Misc|N/A|| |167768|Atazanavir / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A|| |167767|Lamivudine / Lopinavir / Ritonavir / Zidovudine adult regimen|Misc|N/A|| |167767|3TC/AZT/LPV/r adult regimen|Misc|N/A|| |167767|2E - AZT+3TC+LPVr adult|Misc|N/A|| |167766|TDF/DDI/NFV child regimen|Misc|N/A|| |167766|Didanosine / Nelfinavir / Tenofovir child regiment|Misc|N/A|| |167766|5D - TDF+DDI+NFV child|Misc|N/A|| |167765|TDF/DDI/NFV adult regimen|Misc|N/A|| |167765|2D - TDF+DDI+NFV adult|Misc|N/A|| |167765|Didanosine / Nelfinavir / Tenofovir adult regiment|Misc|N/A|| |167764|5C - TDF+DDI+LPV child|Misc|N/A|| |167764|DDI/LPV/TDF child regimen|Misc|N/A|| |167764|Didanosine / Lopinavir / Tenofovir child regimen|Misc|N/A|| |167763|2C - TDF+DDI+LPV adult|Misc|N/A|| |167763|Didanosine / Lopinavir / Tenofovir adult regimen|Misc|N/A|| |167763|2C - TDF+DDI+LPV|Misc|N/A|| |167763|DDI/LPV/TDF adult regimen|Misc|N/A|| |167762|5B - ABC+DDI+NFV child|Misc|N/A|| |167762|Abacavir / Didanosine / Nelfinavir child regimen|Misc|N/A|| |167762|ABC/DDI/NFV child regimen|Misc|N/A|| |167762|5B - ABC+DDL+NFV child|Misc|N/A|| |167761|2B - ABC+DDI+NFV adult|Misc|N/A|| |167761|2B - ABC+DDL+NFV adult|Misc|N/A|| |167761|Abacavir / Didanosine / Nelfinavir adult regimen|Misc|N/A|| |167761|ABC/DDI/NFV adult regimen|Misc|N/A|| |167760|5A - ABC+DDI+LPV child|Misc|N/A|| |167760|Abacavir / Didanosine / Lopinavir child regimen|Misc|N/A|| |167760|ABC/DDI/LPV child regimen|Misc|N/A|| |167759|Abacavir / Didanosine / Lopinavir adult regimen|Misc|N/A|| |167759|2A - ABC+DDI+LPV adult|Misc|N/A|| |167759|ABC/DDI/LPV adult regimen|Misc|N/A|| |167758|Efavirenz / Lamivudine / Stavudine 40 mg child regimen|Misc|N/A|| |167758|d4T(40)/3TC/EFV child regimen|Misc|N/A|| |167758|1B40 - D4T(40)+3TC+EFV|Misc|N/A|| |167757|Efavirenz / Lamivudine / Stavudine 30 mg child regimen|Misc|N/A|| |167757|1B30 - D4T(30)+3TC+EFV|Misc|N/A|| |167757|d4T(30)/3TC/EFV child regimen|Misc|N/A|| |167756|5M - ABC+3TC+DTG child|Misc|N/A|| |167756|Abacavir / Dolutegravir / Lamivudine child regimen|Misc|N/A|| |167756|4J - ABC+3TC+DTG child|Misc|N/A|| |167756|ABC/3TC/DTG child regimen|Misc|N/A|| |167755|5E - ABC+3TC+LPVr child|Misc|N/A|| |167755|3TC/ABC/LPV/r child regimen|Misc|N/A|| |167755|4G - ABC+3TC+LPVr child|Misc|N/A|| |167755|Abacavir / Lamivudine / Lopinavir / Ritonavir child regimen|Misc|N/A|| |167754|5F - AZT+3TC+LPVr child|Misc|N/A|| |167754|4F - AZT+3TC+LPVr child|Misc|N/A|| |167754|Lamivudine / Lopinavir / Ritonavir / Zidovudine child regimen|Misc|N/A|| |167754|3TC/AZT/LPV/r child regimen|Misc|N/A|| |167753|d4T/3TC/EFV child regimen|Misc|N/A|| |167753|4B - D4T+3TC+EFV child|Misc|N/A|| |167753|Efavirenz / Lamivudine / Stavudine child regimen|Misc|N/A|| |167752|Lamivudine / Nevirapine / Stavudine child regimen|Misc|N/A|| |167752|4A - D4T+3TC+NVP child|Misc|N/A|| |167752|d4T/3TC/NVP child regimen|Misc|N/A|| |167751|5N - AZT+3TC+DTG child|Misc|N/A|| |167751|DTG/3TC/AZT child regimen|Misc|N/A|| |167751|Dolutegravir / Lamivudine / Zidovudine child regimen|Misc|N/A|| |167751|4K - AZT+3TC+DTG child|Misc|N/A|| |167750|2K - AZT+3TC+DTG adult|Misc|N/A|| |167750|1K - AZT+3TC+DTG adult|Misc|N/A|| |167750|DTG/3TC/AZT adult regimen|Misc|N/A|| |167750|Dolutegravir / Lamivudine / Zidovudine adult regimen|Misc|N/A|| |167749|5O - TDF+3TC+DTG child|Misc|N/A|| |167749|Dolutegravir / Lamivudine / Tenofovir child regimen|Misc|N/A|| |167749|TDF/3TC/DTG child regimen|Misc|N/A|| |167749|4I - TDF+3TC+DTG child|Misc|N/A|| |167748|2J - TDF+3TC+DTG adult|Misc|N/A|| |167748|Dolutegravir / Lamivudine / Tenofovir adult regimen|Misc|N/A|| |167748|1J - TDF+3TC+DTG adult|Misc|N/A|| |167748|TDF/3TC/DTG adult regimen|Misc|N/A|| |167747|ABC/NVP/3TC adult regimen|Misc|N/A|| |167747|Abacavir / Nevirapine / Lamivudine adult regimen|Misc|N/A|| |167747|1H - ABC+3TC+NVP adult|Misc|N/A|| |167746|1F - TDF+3TC+NVP adult|Misc|N/A|| |167746|3TC/NVP/TDF adult regimen|Misc|N/A|| |167746|Lamivudine / Nevirapine / Tenofovir adult regimen|Misc|N/A|| |167745|5G - TDF+3TC+EFV child|Misc|N/A|| |167745|4E - TDF+3TC+EFV child|Misc|N/A|| |167745|3TC/EFV/TDF child regimen|Misc|N/A|| |167745|Lamivudine / Efavirenz / Tenofovir child regimen|Misc|N/A|| |167744|3TC/EFV/TDF adult regimen|Misc|N/A|| |167744|1E - TDF+3TC+EFV adult|Misc|N/A|| |167744|Lamivudine / Efavirenz / Tenofovir adult regimen|Misc|N/A|| |167743|3TC/AZT/EFV child regimen|Misc|N/A|| |167743|4D - AZT+3TC+EFV child|Misc|N/A|| |167743|Efavirenz / Lamivudine / Zidovudine child regimen|Misc|N/A|| |167742|Efavirenz / Lamivudine / Zidovudine adult regimen|Misc|N/A|| |167742|3TC/AZT/EFV adult regimen|Misc|N/A|| |167742|1D - AZT+3TC+EFV adult|Misc|N/A|| |167741|4C - AZT+3TC+NVP child|Misc|N/A|| |167741|Lamivudine / nevirapine / zidovudine child regimen|Misc|N/A|| |167741|3TC/AZT/NVP child regimen|Misc|N/A|| |167740|3TC/AZT/NVP adult regimen|Misc|N/A|| |167740|Lamivudine / nevirapine / zidovudine adult regimen|Misc|N/A|| |167740|1C - AZT+3TC+NVP adult|Misc|N/A|| |167739|5H - ABC+3TC+EFV child|Misc|N/A|| |167739|4L - ABC+3TC+EFV child|Misc|N/A|| |167739|4L - ABC+3TC+EFV|Misc|N/A|| |167739|3TC/ABC/EFV child regimen|Misc|N/A|| |167739|Abacavir / Efavirenz / Lamivudine child regimen|Misc|N/A|| |167738|1G - ABC+3TC+EFV adult|Misc|N/A|| |167738|1g - ABC+3TC+EFV|Misc|N/A|| |167738|1g - ABC+3TC+EFV regimen|Misc|N/A|| |167738|3TC/ABC/EFV adult regimen|Misc|N/A|| |167738|Abacavir / Efavirenz / Lamivudine adult regimen|Misc|N/A|| |167737|Violence condition as stressor|Question|Coded|| |167736|Family condition as stressor|Question|Coded|| |167735|Social condition as stressor|Question|Coded|| |167734|Medical condition as stressor|Question|Coded|| |167733|Follow-up patient|Question|Coded|| |167733|Returning patient|Question|Coded|| |167732|Transfer to other health care facility|Procedure|N/A|| |167731|Internal facility transfer/referral|Procedure|N/A|| |167731|Intra-facility transfer/referral|Procedure|N/A|| |167730|Intentional delayed separation of umbilical cord|Procedure|N/A|| |167730|Delayed cord clamping|Procedure|N/A|| |167730|Delayed separation of umbilical cord|Procedure|N/A|| |167729|Respiratory assessment score|Question|Numeric|| |167728|Silverman-Anderson respiratory assessment|Procedure|N/A|| |167727|Downes respiratory assessment|Procedure|N/A|| |167726|History of administration of maternal corticosteroid administration for fetal lung maturation|Question|Coded|| |167725|Newborn received HIV post-exposure prophylaxis|Question|Coded|| |167724|Radiant warming of newborn|Procedure|N/A|| |167724|Active radiant warming of infant|Procedure|N/A|| |167723|> 6 wks|Misc|N/A|| |167723|> 6 wks|Misc|N/A|| |167723|Greater than 6 weeks|Misc|N/A|| |167722|Six weeks|Misc|N/A|| |167722|6 weeks|Misc|N/A|| |167722|6 wks|Misc|N/A|| |167721|< 6 wks|Misc|N/A|| |167721|< 6 wks|Misc|N/A|| |167721|Less than 6 weeks|Misc|N/A|| |167720|Late-onset neonatal sepsis|Diagnosis|N/A|| |167719|MDA|Misc|N/A|Country in Eastern Europe| |167719|Republic of Moldova|Misc|N/A|Country in Eastern Europe| |167718|CD4 count result (qualitative)|Question|Coded|| |167717|CD4 count <=200 cells/uL|Finding|N/A|| |167717|CD4 count <=200 cells/mm3|Finding|N/A|| |167717|CD4 count <=200 cells/uL|Finding|N/A|| |167717|CD4 count less than or equal to 200|Finding|N/A|| |167717|CD4 count <=200 cells/uL|Finding|N/A|| |167716|Sofosbuvir / Velpatasvir + Ribavirin|Misc|N/A|Medication regimen containing three drugs|
Hello @jwnasambu , This is the latest version of CIEL that you should import. Hope you have access to the Dropbox.